{
  "meta": {
    "title": "52_Previous_Year_Questions",
    "url": "https://brainandscalpel.vercel.app/52-previous-year-questions-b383bc41.html",
    "scrapedAt": "2025-11-30T18:17:03.242Z"
  },
  "questions": [
    {
      "text": "Which of the following is not correctly matched?",
      "choices": [
        {
          "id": 0,
          "text": "Andexanet alfa : Edoxaban"
        },
        {
          "id": 1,
          "text": "Andexanet alfa : Rivaroxaban"
        },
        {
          "id": 2,
          "text": "Idarucizumab : Dabigatran"
        },
        {
          "id": 3,
          "text": "Ciraparantag : Fondaparinux"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer D - Ciraparantag: Fondaparinux </strong></p>\n\n<ul>\n\t<li><strong>Ciraparantag</strong> is a <span class=\"customMeta\" data-dictid=\"82343f61171692777197b4a08bc719\">reversal</span> agent for all several anticoagulants such as <strong>direct</strong> <strong>factor</strong> <strong>Xa</strong> <strong>inhibitors</strong> (rivaroxaban, <span class=\"customMeta\" data-dictid=\"bd0e99d93a169277718152523f2534\">apixaban</span> and edoxaban), dabigatran, and heparins</li>\n\t<li><strong>Fondaparinux</strong> is an <strong>indirect</strong> <strong>factor</strong> <strong>Xa</strong> <strong>inhibitor</strong> that is used to prevent blood clots in patients undergoing surgery, those with <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"bc8bc758371692777185eff2ccabb7\">coronary</span> syndromes, and those at risk for <span class=\"customMeta\" data-dictid=\"712bb2d2b716927771867d5505033c\">deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis</span> and <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> embolism.</li>\n</ul>\n\n<p><strong>Andexanet alfa (Option A and B) </strong>is a <span class=\"customMeta\" data-dictid=\"b566321fe8169277719716b1cf4df0\">recombinant</span> modified human factor Xa protein that acts as a decoy molecule to bind and <span class=\"customMeta\" data-dictid=\"08af02471516927771988150ca6e24\">sequester</span> factor Xa inhibitors such as <strong>edoxaban and rivaroxaban</strong>. This effectively reverses their <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> effect and restores normal blood <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> in patients who are experiencing <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> or require urgent surgery.</p>\n\n<p><strong>Idarucizumab (Option C) </strong>is a <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> fragment that specifically binds to <strong>dabigatran</strong>, a direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitor, and neutralises its <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> effect. It was approved by the FDA in 2015 for the <span class=\"customMeta\" data-dictid=\"82343f61171692777197b4a08bc719\">reversal</span> of dabigatran in emergency situations such as life-threatening <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> or the need for urgent surgery.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A patient with known rheumatic heart disease is now found to have a 1–2 cm aneurysm on imaging. What is the most appropriate next step in management?",
      "choices": [
        {
          "id": 0,
          "text": "Aspirin lifelong"
        },
        {
          "id": 1,
          "text": "Aspirin + Clopidogrel"
        },
        {
          "id": 2,
          "text": "Aspirin for 3 weeks"
        },
        {
          "id": 3,
          "text": "IV antibiotics"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">Aspirin</span> lifelong</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>A <strong>1–2 cm <span class=\"customMeta\" data-dictid=\"bc8bc758371692777185eff2ccabb7\">coronary</span> <span class=\"customMeta\" data-dictid=\"a66cd3adaa1692777182e77cb23021\">artery</span> aneurysm</strong> (10–20 mm) falls in the category of a <strong>large aneurysm</strong>, which significantly increases the risk of <strong>intraluminal thrombosis, <span class=\"customMeta\" data-dictid=\"5ff25303a01692777186731f6a4f5c\">distal</span> embolization, and myocardial infarction</strong>.</li>\n\t<li>Long-term <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> therapy with <strong>low-dose aspirin</strong> is recommended to reduce thrombotic risk in such patients.</li>\n\t<li>In the absence of active infection, <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> thrombosis, or other complicating factors, <strong>lifelong aspirin</strong> remains the cornerstone of therapy.</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<ul>\n\t<li><strong>Aspirin + Clopidogrel (Option B):</strong> Dual <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> therapy (DAPT) is used in <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"bc8bc758371692777185eff2ccabb7\">coronary</span> syndromes, stenting, or in certain high-risk giant aneurysms, but not routinely for stable large aneurysms without <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> events.</li>\n\t<li><strong>Aspirin for 3 weeks (Option C):</strong> This short course is inadequate for an <span class=\"customMeta\" data-dictid=\"f2c92eaffe16927771819978aa5666\">aneurysm</span> of this size because thrombotic risk persists long-term.</li>\n\t<li><strong>IV antibiotics (Option D):</strong> Indicated for <strong>infective endocarditis</strong> or infected aneurysms; not required here as there are no signs of infection.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "At what point should we transition a pregnant woman with a prosthetic valve and rheumatic heart disease from warfarin to heparin?",
      "choices": [
        {
          "id": 0,
          "text": "32 weeks"
        },
        {
          "id": 1,
          "text": "36 weeks"
        },
        {
          "id": 2,
          "text": "37 weeks"
        },
        {
          "id": 3,
          "text": "40 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Option C: 37 Weeks</strong></p>\n\n<ul>\n\t<li>When managing a pregnant female with rheumatic heart disease, especially with a <span class=\"customMeta\" data-dictid=\"c936e2cd131692777196b1d877f678\">prosthetic</span> valve, the management of <span class=\"customMeta\" data-dictid=\"9beeeb58f6169277718129acb7bd01\">anticoagulation</span> therapy is crucial to balance the risks of thromboembolic events and <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> complications.</li>\n</ul>\n\n<p> </p>\n\n<ul>\n\t<li><strong>Before 36 weeks of gestation</strong>\n\n\t<ul>\n\t\t<li>Oral VKA therapy is recommended: daily <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> dose requirement of ≤ 5mg</li>\n\t\t<li>Replace VKAs by LMWH and UFH if <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> dose > 5mg</li>\n\t</ul>\n\t</li>\n\t<li><strong>After 36 weeks of gestation</strong>\n\t<ul>\n\t\t<li>The ACC/AHA guidelines suggest stopping <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> at 36 weeks and starting Continuous IV UFH</li>\n\t\t<li>In the absence of significant bleeding, oral <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> should then be initiated 24 hours after the birth</li>\n\t</ul>\n\t</li>\n\t<li>So the correct answer is 37 weeks </li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A, B and D:</strong> In a rheumatic heart disease pregnant female with <span class=\"customMeta\" data-dictid=\"c936e2cd131692777196b1d877f678\">prosthetic</span> valve, we should switch to <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> at 37 weeks (After 36 weeks of gestation), so these options are incorrect </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the statements below correctly describes pegylated filgrastim?",
      "choices": [
        {
          "id": 0,
          "text": "Duration of action is shorter than normal filgrastim"
        },
        {
          "id": 1,
          "text": "Added advantage is that it can be taken orally"
        },
        {
          "id": 2,
          "text": "It should not be administered in sickle cell patients"
        },
        {
          "id": 3,
          "text": "It is not effective in the treatment of severe neutropenia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Option C: Pegylated-filgrastim should not be administered in sickle cell patients.</strong></p>\n\n<p><strong>Option C. It should</strong> <strong>not be administered in sickle cell patients</strong>: Pegylated-filgrastim is contraindicated in sickle cell patients. It can <strong>potentially stimulate the production of sickled red blood cells, </strong>leading to <strong>vaso-occlusive crises</strong> and<strong> worsening of sickle cell disease symptoms.</strong></p>\n\n<p><strong>Incorrect options:</strong></p>\n\n<p><strong>Option A. Duration of action is shorter than normal filgrastim:</strong> Pegylated-filgrastim has a longer duration of action compared to normal filgrastim. The addition of <span class=\"customMeta\" data-dictid=\"6f2c4e308c16927771964ef7064e47\">polyethylene</span> <span class=\"customMeta\" data-dictid=\"7451dcad4f1692777188609e12be1d\">glycol</span> (PEG) to <span class=\"customMeta\" data-dictid=\"961cab02fe1692777202b03db9637d\">filgrastim</span> prolongs its half-life, resulting in sustained release and a longer duration of action.</p>\n\n<p><strong>Option B. Added advantage is that it can be taken orally</strong>: Pegylated-filgrastim is not available in an oral form. It is typically administered via <span class=\"customMeta\" data-dictid=\"d446e62c6c1692777199896fc1d4b9\">subcutaneous</span> injection.</p>\n\n<p><strong>Option D. It is not effective in the treatment of severe neutropenia</strong>: Pegylated-filgrastim is effective in the treatment of severe neutropenia. It stimulates the production of neutrophils and helps reduce the duration and severity of neutropenia, which is a condition characterized by a low <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> count.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A child accidentally took a bottle full of iron tablets. Which of the drugs is used as an antidote for iron poisoning?",
      "choices": [
        {
          "id": 0,
          "text": "Luspatercept"
        },
        {
          "id": 1,
          "text": "Deferoxamine"
        },
        {
          "id": 2,
          "text": "Deferiprone"
        },
        {
          "id": 3,
          "text": "DMSA"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer B - Deferoxamine<br />\n<br />\nExplanation: </strong></p>\n\n<ul>\n\t<li>Acute iron <span class=\"customMeta\" data-dictid=\"072b8af16e1692777196f21b086f92\">poisoning</span> can occur when a person ingests a toxic amount of iron tablets or other iron-containing substances.</li>\n\t<li>Deferoxamine is a <span class=\"customMeta\" data-dictid=\"f4305306cd16927771847a63caf4c7\">chelating agent</span> that is used as the <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> for <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">Acute</span> iron poisoning.</li>\n\t<li><strong>Mechanism:</strong> Binds iron in the body and forms a stable complex that can be excreted through <span class=\"customMeta\" data-dictid=\"0096f2a7631692777201eb9f21d5a7\">urine</span> and faeces.</li>\n\t<li>Deferoxamine helps to remove <span class=\"customMeta\" data-dictid=\"7a1ae24f701692777187a7f60bbd9f\">excess</span> iron from the body and prevent its toxic effects.</li>\n</ul>\n\n<p><strong>Luspatercept (Option A) </strong>is a medication used for the treatment of <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> in certain blood disorders and is not indicated for the treatment of iron poisoning.</p>\n\n<p><strong>Deferiprone (Option C) </strong>is an oral <span class=\"customMeta\" data-dictid=\"f4305306cd16927771847a63caf4c7\">chelating agent</span> used to treat <span class=\"customMeta\" data-dictid=\"64bbd63a0c1692777190f0c8e06e91\">iron overload</span> in disorders like thalassemia. However, <span class=\"customMeta\" data-dictid=\"423bba3d10169277718536aa18aea0\">deferoxamine</span> is the preferred <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> for <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> iron poisoning.</p>\n\n<p><strong>DMSA (Dimercaptosuccinic acid) (Option D) </strong>is another <span class=\"customMeta\" data-dictid=\"f4305306cd16927771847a63caf4c7\">chelating agent</span> used for <span class=\"customMeta\" data-dictid=\"6e8ada09fa1692777189bfbace851a\">heavy metal</span> poisoning, but it is not the preferred <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> for iron poisoning. It is more commonly used for lead or <span class=\"customMeta\" data-dictid=\"b59bbde2f816927771924bb2b17b64\">mercury</span> poisoning.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A patient on anti-cancer therapy developed an infection. Blood analysis revealed a total leucocyte count of 2000/mm3. Which of the following drugs is likely to be effective in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Romiplostim"
        },
        {
          "id": 1,
          "text": "Oprelvekin"
        },
        {
          "id": 2,
          "text": "Filgrastim"
        },
        {
          "id": 3,
          "text": "Erythropoietin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer C - Filgrastim</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>In patients with <strong>chemotherapy-induced neutropenia</strong> (low <span class=\"customMeta\" data-dictid=\"57176262ed169277720233ee0ceb2a\">white blood cell</span> count, particularly neutrophils), Filgrastim is most likely to be effective in this patient.</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"3\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Drugs promoting WBC formation</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Drug Name</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Mechanism of Action</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Clinical Uses</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>G-CSF</strong></p>\n\n\t\t\t<p>(Glycoprotein with 175 <span class=\"customMeta\" data-dictid=\"543f207eb51692777181723491a358\">amino</span> acids)</p>\n\t\t\t</td>\n\t\t\t<td rowspan=\"3\" style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none\">\n\t\t\t<ul>\n\t\t\t\t<li>Stimulates colony-forming unit (CFU) granulocytes to increase <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> production.</li>\n\t\t\t\t<li>Enhances <span class=\"customMeta\" data-dictid=\"b68a8f1b37169277719547f1cfda59\">phagocytic</span> and cytotoxic activities of neutrophils.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Treats severe <span class=\"customMeta\" data-dictid=\"3925bbe5df1692777193bd03c159a8\">neutropenia</span> after <span class=\"customMeta\" data-dictid=\"0a266da66816927771824d58668832\">autologous</span> <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> <span class=\"customMeta\" data-dictid=\"467c0b4fc016927771997e1043aeda\">stem cell transplantation</span> and high-dose cancer chemotherapy</li>\n\t\t\t\t<li>Treats severe <span class=\"customMeta\" data-dictid=\"488a4efe7d16927771840c9e29f164\">congenital</span> neutropenias</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Filgrastim</strong></p>\n\n\t\t\t<p>(Recombinant human G-CSF)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Same use as G-CSF</li>\n\t\t\t\t<li>Treats <span class=\"customMeta\" data-dictid=\"3925bbe5df1692777193bd03c159a8\">neutropenia</span> in patients with AIDS receiving zidovudine</li>\n\t\t\t\t<li>Used in patients undergoing <span class=\"customMeta\" data-dictid=\"255674f3271692777195c172d86daf\">peripheral</span> blood stem cell collection for stem cell transplantation</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>PEG-Filgrastim</strong></p>\n\n\t\t\t<p>(Longer acting <span class=\"customMeta\" data-dictid=\"761475dbbd169277719523f180ef28\">pegylated</span> <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of G-CSF)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Prevention of chemotherapy-induced neutropenia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Sargramostim</strong></p>\n\n\t\t\t<p>(Recombinant human GM-CSF)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p>Stimulates myelopoiesis</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Autologous <span class=\"customMeta\" data-dictid=\"c8a8c935a41692777191610f6aacb4\">marrow</span> <span class=\"customMeta\" data-dictid=\"ee9f07b0a81692777200e416e4e5d7\">transplantation</span> treatment</li>\n\t\t\t\t<li>Mobilizes CD34+ progenitor cells for <span class=\"customMeta\" data-dictid=\"255674f3271692777195c172d86daf\">peripheral</span> blood stem cell collection post-myeloablative chemotherapy</li>\n\t\t\t\t<li>Treats <span class=\"customMeta\" data-dictid=\"3925bbe5df1692777193bd03c159a8\">neutropenia</span> in patients on <span class=\"customMeta\" data-dictid=\"901bf573f216927771905f0abedca2\">intensive</span> cancer chemotherapy</li>\n\t\t\t\t<li>Supports <span class=\"customMeta\" data-dictid=\"9a34416acd16927771930416df6115\">myelopoiesis</span> in <span class=\"customMeta\" data-dictid=\"1d84248e9f16927771850f8b75c26a\">cyclic</span> neutropenia, myelodysplasia, <span class=\"customMeta\" data-dictid=\"1ea06afcbd1692777181199bfa3300\">aplastic</span> anemia, and AIDS-associated neutropenia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Molgramostim</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p>Targets GM-CSF receptors on <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> <span class=\"customMeta\" data-dictid=\"ae13cdc5c3169277719683e9f6bda5\">precursor</span> cells</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Increases granulocytes and monocytes</li>\n\t\t\t\t<li>Approved for chemotherapy-induced neutropenia</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><strong>Romiplostim & Oprelvekin (Option A and B) </strong>are not indicated for the treatment of infection or low <span class=\"customMeta\" data-dictid=\"00346a7f211692777191e91c2af9fc\">leukocyte</span> count. <strong>Romiplostim</strong> is a <span class=\"customMeta\" data-dictid=\"b084a2ed0d1692777200e64e4a9b54\">thrombopoietin</span> <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> <span class=\"customMeta\" data-dictid=\"7d8d28cda71692777180c89a3c86ce\">agonist</span> used to increase <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> production in patients with <span class=\"customMeta\" data-dictid=\"fc28c74bb716927772003aee4aa43c\">thrombocytopenia</span> and low <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> count. <strong>Oprelvekin</strong> is a <span class=\"customMeta\" data-dictid=\"b566321fe8169277719716b1cf4df0\">recombinant</span> <span class=\"customMeta\" data-dictid=\"e5391c3f5e1692777190b226153f77\">interleukin-11</span> that stimulates <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> production in patients with severe thrombocytopenia.<br />\n<br />\n<strong>Erythropoietin (Option D) </strong>is a hormone that stimulates the production of red blood cells and is used to treat anemia, not low <span class=\"customMeta\" data-dictid=\"00346a7f211692777191e91c2af9fc\">leukocyte</span> count or infection.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which drug acts on the rounded up enzyme?",
      "choices": [
        {
          "id": 0,
          "text": "Aminocapric acid"
        },
        {
          "id": 1,
          "text": "Tenecteplase"
        },
        {
          "id": 2,
          "text": "Streptokinase"
        },
        {
          "id": 3,
          "text": "Apixaban"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer: A) Aminocaproic Acid</strong></p>\n\n<p><strong>Explanation:</strong></p>\n\n<ul>\n\t<li>\n\t<p><strong>Aminocaproic acid</strong> is an <span class=\"customMeta\" data-dictid=\"03b359edf81692777181e4a297fbf8\">antifibrinolytic</span> agent that competitively inhibits <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> activators and, to a lesser extent, binds to plasminogen, preventing its conversion to plasmin.</p>\n\t</li>\n\t<li>\n\t<p>This stabilizes <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> clots by reducing fibrinolysis, similar to PAI-1’s effect of inhibiting tPA/uPA to limit <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">plasmin</span> formation.</p>\n\t</li>\n\t<li>\n\t<p>By <span class=\"customMeta\" data-dictid=\"9dc12b322016927771830dff673eeb\">blocking</span> <span class=\"customMeta\" data-dictid=\"efd9265c421692777202931bbcc4be\">fibrinolysis</span> at the <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> step, <span class=\"customMeta\" data-dictid=\"fc966eaa141692777181d46aae2190\">aminocaproic acid</span> complements PAI-1’s role in maintaining <span class=\"customMeta\" data-dictid=\"5e0b40993316927771844dbf382689\">clot</span> integrity, making it the drug of choice in conditions of excessive <span class=\"customMeta\" data-dictid=\"efd9265c421692777202931bbcc4be\">fibrinolysis</span> (e.g., <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> disorders like <span class=\"customMeta\" data-dictid=\"904d77ba8a16927771882396edef7c\">hemophilia</span> or post-surgical bleeding).</p>\n\t</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Tenecteplase (Option B) </strong>is a <span class=\"customMeta\" data-dictid=\"f43fcbd30c1692777202bae15ef702\">fibrinolytic</span> (thrombolytic) agent that works by directly activating <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> to plasmin, which breaks down <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> clots. <span class=\"customMeta\" data-dictid=\"da8d3139e016927772009d11ecfb67\">Tenecteplase</span> does not act on PAI-1; instead, its action would be opposed by PAI-1 because PAI-1 inhibits tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> (tPA), reducing the <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> of plasminogen.</p>\n\n<p><strong>Streptokinase (Option C)</strong> is another <span class=\"customMeta\" data-dictid=\"f43fcbd30c1692777202bae15ef702\">fibrinolytic</span> agent that works by forming a complex with plasminogen, leading to the formation of <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">plasmin</span> and subsequent <span class=\"customMeta\" data-dictid=\"903370f259169277718385f6060dd7\">breakdown</span> of clots. Like tenecteplase, streptokinase's action is not directly on PAI-1, but rather on plasminogen, and its activity can be inhibited by PAI-1.</p>\n\n<p><strong>Apixaban (Option D)</strong> is an <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> that works by directly inhibiting Factor Xa, an essential <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> in the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> cascade. Apixaban does not interact with the <span class=\"customMeta\" data-dictid=\"f43fcbd30c1692777202bae15ef702\">fibrinolytic</span> system or PAI-1, and its mechanism of action is unrelated to PAI-1 or <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> activation.</p>",
      "question_images": [
        "https://image.prepladder.com/content/49xiCCgCoewjq8hfNZb11724836291.png"
      ],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A patient with a history of ischemic stroke was started on clopidogrel. However, she had another stroke after 6 months. Which of the following could be responsible for the failure of clopidogrel in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Reduced activity of CYP2C19"
        },
        {
          "id": 1,
          "text": "Downregulation of CYP2D6"
        },
        {
          "id": 2,
          "text": "Upregulation of CYP1A1"
        },
        {
          "id": 3,
          "text": "Downregulation of CYP2E1"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p>Correct Answer: A) <span class=\"customMeta\" data-dictid=\"10c83adb331692777197f775bec1aa\">Reduced</span> activity of CYP2C19</p>\n\n<p> </p>\n\n<p>Explanation: </p>\n\n<p>Clopidogrel is a <span class=\"customMeta\" data-dictid=\"1c0d8a64fa1692777196f90166732c\">prodrug</span> that requires activation by CYP2C19 to become an active <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> medication thus, reduced activity of the CYP2C19 is most likely the reason for the failure of clopidogrel in this patien.t</p>\n\n<p> </p>\n\n<table>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" rowspan=\"1\">\n\t\t\t<p>Clopidogrel</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" rowspan=\"1\">\n\t\t\t<p>Clopidogrel is a <span class=\"customMeta\" data-dictid=\"1c0d8a64fa1692777196f90166732c\">prodrug</span> that requires <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> by CYP2C19 to become an active <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> drug.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Activation </p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<ul>\n\t\t\t\t<li>CYP2C19 is an <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> found in the liver and is responsible for converting clopidogrel into its active form.</li>\n\t\t\t\t<li>Certain genetic polymorphisms or drug interactions can lead to <span class=\"customMeta\" data-dictid=\"10c83adb331692777197f775bec1aa\">reduced</span> activity of CYP2C19, and the <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> of clopidogrel may be reduced</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Uses </p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<ul>\n\t\t\t\t<li>Post Myocardial infarction</li>\n\t\t\t\t<li>Post <span class=\"customMeta\" data-dictid=\"75a3b02a801692777184b9cb7f0c0a\">cerebrovascular</span> accidents</li>\n\t\t\t\t<li>Peripheral arterial diseases</li>\n\t\t\t\t<li>Acute <span class=\"customMeta\" data-dictid=\"bc8bc758371692777185eff2ccabb7\">coronary</span> syndrome</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Adverse effects</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<ul>\n\t\t\t\t<li>Risk of <span class=\"customMeta\" data-dictid=\"41e858bf2816927771836d46c619b9\">bleeding</span> if used with anticoagulants or antiplatelets</li>\n\t\t\t\t<li>Rare - thrombotic thrombocytopenic purpura</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p> </p>\n\n<table>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Enzyme</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Substrate</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>CYP2D6</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>SSRIs, Opiates, Beta-blockers, <span class=\"customMeta\" data-dictid=\"66bf14385516927772001b3646b855\">tricyclic</span> antidepressants</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>CYP1A1/2</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Theophylline, Paracetamol, caffeine</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>CYP2E1</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>Alcohol, halothane, Paracetamol</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What is the mechanism of action of alteplase, a tissue plasminogen activator (tPA)?",
      "choices": [
        {
          "id": 0,
          "text": "Inhibits Vitamin K-dependent factors"
        },
        {
          "id": 1,
          "text": "Inhibits factor X"
        },
        {
          "id": 2,
          "text": "Promotes fibrinolysis"
        },
        {
          "id": 3,
          "text": "Activation of thrombin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer C - Promotes fibrinolysis</strong></p>\n\n<ul>\n\t<li><strong>Alteplase</strong> is a <strong>tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> (tPA)</strong> that promotes <span class=\"customMeta\" data-dictid=\"efd9265c421692777202931bbcc4be\">fibrinolysis</span> by converting <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> to plasmin, which in turn breaks down <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> in blood clots.</li>\n</ul>\n\n<table align=\"left\" cellspacing=\"0\" style=\"border-collapse:collapse\">\n\t<thead>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Fibrinolytic Drugs (Thrombolytics)</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:none; border-left:none; border-right:none; border-top:none\"> </td>\n\t\t</tr>\n\t</thead>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Mechanism</strong></p>\n\t\t\t</td>\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Activate <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> to <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">plasmin</span> via tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> (t-PA)</strong>→ digests <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> →lyse <span class=\"customMeta\" data-dictid=\"fc23eb4c0a16927772003dff4101cd\">thrombi</span> to recanalize occluded blood vessels, primarily <span class=\"customMeta\" data-dictid=\"bc8bc758371692777185eff2ccabb7\">coronary</span> arteries.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:none; border-left:none; border-right:none; border-top:none\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:none; border-left:none; border-right:none; border-top:none\"> </td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Examples </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Streptokinase (not in use)</li>\n\t\t\t\t<li>Urokinase (not in use)</li>\n\t\t\t\t<li><strong>Alteplase </strong></li>\n\t\t\t\t<li>Reteplase</li>\n\t\t\t\t<li>Tenecteplase</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:none; border-left:none; border-right:none; border-top:none\">\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Uses</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Acute Myocardial <span class=\"customMeta\" data-dictid=\"77aed446d2169277719007f42bf052\">Infarction</span> (STEMI)\n\t\t\t\t<ul>\n\t\t\t\t\t<li>The chief indication is for STEMI.</li>\n\t\t\t\t\t<li>Not indicated for unstable <span class=\"customMeta\" data-dictid=\"030cd51b341692777181d15302c8d4\">angina</span> (UA) and low-risk NSTEMI.</li>\n\t\t\t\t\t<li>Alternative to emergency PCI.</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\n\t\t\t<ul>\n\t\t\t\t<li>Deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">Vein</span> <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">Thrombosis</span> (DVT)</li>\n\t\t\t</ul>\n\n\t\t\t<ul>\n\t\t\t\t<li>Pulmonary <span class=\"customMeta\" data-dictid=\"1c07a1135f1692777187f547678386\">Embolism</span> (PE)\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Indicated for large, life-threatening PE</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\n\t\t\t<ul>\n\t\t\t\t<li>Peripheral Arterial Occlusion\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Indicated when <span class=\"customMeta\" data-dictid=\"81d12f9cb01692777199e44ff3f3c1\">surgical</span> <span class=\"customMeta\" data-dictid=\"b5771b30e816927772007c88fd4e29\">thrombectomy</span> is not possible.</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\n\t\t\t<ul>\n\t\t\t\t<li>Stroke (Ischemic Stroke)\n\t\t\t\t<ul>\n\t\t\t\t\t<li>Alteplase is approved</li>\n\t\t\t\t\t<li>Contraindicated after 4.5 hours of symptom onset due to increased <span class=\"customMeta\" data-dictid=\"cd42e0ddad1692777190d18c595ec5\">intracranial</span> <span class=\"customMeta\" data-dictid=\"4642acfc0c16927771880b34fa5174\">hemorrhage</span> risk.</li>\n\t\t\t\t</ul>\n\t\t\t\t</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:none; border-left:none; border-right:none; border-top:none\">\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Contraindications </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>History of <span class=\"customMeta\" data-dictid=\"cd42e0ddad1692777190d18c595ec5\">intracranial</span> hemorrhage.</li>\n\t\t\t\t<li>History of <span class=\"customMeta\" data-dictid=\"bef027ba821692777190cb424e9554\">ischemic stroke</span> in the past 3 months.</li>\n\t\t\t\t<li>History of head injury in the past 3 months.</li>\n\t\t\t\t<li>Intracranial tumor/vascular abnormality/aneurysms.</li>\n\t\t\t\t<li>Active bleeding/bleeding disorders.</li>\n\t\t\t\t<li>Patients on anticoagulants.</li>\n\t\t\t\t<li>Peptic ulcer, <span class=\"customMeta\" data-dictid=\"192677035a169277718780b4d6dbbb\">esophageal</span> varices.</li>\n\t\t\t\t<li>Recent wound, fracture, or tooth extraction.</li>\n\t\t\t\t<li>Major surgery within the past 3 weeks.</li>\n\t\t\t\t<li>Uncontrolled hypertension.</li>\n\t\t\t\t<li><strong>Pregnancy.</strong></li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:none; border-left:none; border-right:none; border-top:none\">\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><strong>Inhibits Vitamin K-dependent factors (Option A)</strong> is characteristic of anticoagulants like warfarin, which <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> the <span class=\"customMeta\" data-dictid=\"3fda45538a1692777199ec2a5478a5\">synthesis</span> of <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors II, VII, IX, and X. <span class=\"customMeta\" data-dictid=\"fcf301c929169277718150daaaafc4\">Alteplase</span> does not work by inhibiting these factors.</p>\n\n<p><strong>Inhibits factor</strong> <strong>X (Option B) </strong>is the action of direct oral anticoagulants (DOACs) like <strong>rivaroxaban or apixaban.</strong> <span class=\"customMeta\" data-dictid=\"fcf301c929169277718150daaaafc4\">Alteplase</span> does not target Factor X; instead, it activates <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> to <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">plasmin</span> to break down fibrin.</p>\n\n<p><strong>Activation of <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> (Option D)</strong> is involved in <span class=\"customMeta\" data-dictid=\"5e0b40993316927771844dbf382689\">clot</span> formation by converting <span class=\"customMeta\" data-dictid=\"a137b7092a16927772025412d4ef05\">fibrinogen</span> to fibrin. <span class=\"customMeta\" data-dictid=\"fcf301c929169277718150daaaafc4\">Alteplase</span> does not <span class=\"customMeta\" data-dictid=\"dddc752e1716927771807f985bb8bb\">activate</span> thrombin. Instead, it promotes <span class=\"customMeta\" data-dictid=\"efd9265c421692777202931bbcc4be\">fibrinolysis</span> by activating plasminogen, which cleaves <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> and dissolves clots.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A young boy with a history of multiple blood transfusions presents with bone pain for the past 6 months. A peripheral smear showed sickle-shaped RBCs. Which of the following drugs are not used in the treatment of his condition?",
      "choices": [
        {
          "id": 0,
          "text": "Bebtelovimab"
        },
        {
          "id": 1,
          "text": "Voxelotor"
        },
        {
          "id": 2,
          "text": "Hydroxyurea"
        },
        {
          "id": 3,
          "text": "L-glutamine"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer: A) Bebtelovimab</strong></p>\n\n<p> </p>\n\n<p><strong>Explanation: </strong></p>\n\n<ul>\n\t<li>The drug<strong> not used in treating sickle cell disease (SCD)</strong> in the given scenario is<strong> Bebtelovimab.</strong></li>\n\t<li>Bebtelovimab is a <strong>monoclonal <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> </strong>against the <span class=\"customMeta\" data-dictid=\"1931730fd41692777199bf164f574c\">spike</span> protein of SARS-CoV2.</li>\n\t<li>It is used for the treatment of<strong> <span class=\"customMeta\" data-dictid=\"2d364aeaf7169277718529fa58f6ea\">COVID-19</span> </strong>and reduces the risk of hospitalisation and death.</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:754px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"5\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Pharmacological Treatments for sickle cell anemia</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Drug</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Hydroxyurea</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Voxelotor</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Crizanlizumab</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>L-Glutamine</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>MOA</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Increases <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> (HbF) levels.</li>\n\t\t\t\t<li>Reduces sickle <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> (HbS) polymerization.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Increases hemoglobin's <span class=\"customMeta\" data-dictid=\"227269f3ec1692777180d76a7898dd\">affinity</span> for oxygen.</li>\n\t\t\t\t<li>Reduces <span class=\"customMeta\" data-dictid=\"a4f67f90fa169277719829965d14e9\">sickling</span> and hemolysis.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Blocks P-selectin to prevent sickle cell-endothelial adhesion.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Reduces <span class=\"customMeta\" data-dictid=\"60d563fe241692777194203742bf5b\">oxidative</span> stress in sickle erythrocytes.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Use</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Standard care for all patients with sickle cell <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> and HbS-β0 thalassemia.</li>\n\t\t\t\t<li>It is used for patients of all ages regardless of the symptoms.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Improves <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> levels in sickle cell disease patients.</li>\n\t\t\t\t<li>It is added with <span class=\"customMeta\" data-dictid=\"ac923489f3169277718998b7f862df\">hydroxyurea</span> for <span class=\"customMeta\" data-dictid=\"8fabe131a916927771802a448a329c\">additive</span> results especially in adults when the symptoms are not sufficiently <span class=\"customMeta\" data-dictid=\"10c83adb331692777197f775bec1aa\">reduced</span> by <span class=\"customMeta\" data-dictid=\"ac923489f3169277718998b7f862df\">hydroxyurea</span> alone.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Reduces frequency of painful crises.</li>\n\t\t\t\t<li>Can be added with <span class=\"customMeta\" data-dictid=\"ac923489f3169277718998b7f862df\">hydroxyurea</span> and Voxelotor for <span class=\"customMeta\" data-dictid=\"8fabe131a916927771802a448a329c\">additive</span> results when the vaso <span class=\"customMeta\" data-dictid=\"3cd09dcb0e1692777194e41a18d184\">occlusive</span> complications still continue with these medications at the right doses.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Helps manage pain episodes.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Dosage</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Start at ~20 mg/kg for children.</li>\n\t\t\t\t<li>Titrate to the <span class=\"customMeta\" data-dictid=\"86ef7aab6c1692777191067c2c9040\">maximum tolerated dose</span> based on blood counts.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>1500 mg daily.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Administer intravenously once a month.</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Specific <span class=\"customMeta\" data-dictid=\"b5bd69c9791692777186a40f45ffb6\">dosage</span> determined in clinical trials.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Important Details</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Reduces pain crises and <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> chest syndrome by ~50%.</li>\n\t\t\t\t<li>Treatment is initiated in the first year of life.</li>\n\t\t\t\t<li>Long-term use has decreased mortality.</li>\n\t\t\t\t<li>Increases <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> by about 1 gm/dL.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Associated with a 1 g/dL increase in <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> in 59% of patients.</li>\n\t\t\t\t<li>Long-term benefits and safety are under investigation.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Associated with a ~45% reduction in <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> painful episodes.</li>\n\t\t\t\t<li>No significant effect on <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> is observed.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Shows a 25% reduction in painful episodes.</li>\n\t\t\t\t<li>Associated with a 33% decrease in hospitalizations compared to placebo.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p> </p>\n\n<p> </p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "G6PD (Glucose 6-phosphate dehydrogenase) can manifest with which of the following drugs?",
      "choices": [
        {
          "id": 0,
          "text": "Primaquine"
        },
        {
          "id": 1,
          "text": "Mefloquine"
        },
        {
          "id": 2,
          "text": "Penicillin"
        },
        {
          "id": 3,
          "text": "Tetracycline"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<ul>\n\t<li>Primaquine is an <span class=\"customMeta\" data-dictid=\"7f56a9f82e1692777181c7810a4c8b\">antimalarial</span> drug that can cause <strong>hemolysis</strong> in individuals with <strong>G6PD deficiency.</strong></li>\n\t<li>Glucose-6-phosphate <span class=\"customMeta\" data-dictid=\"0d1ed86c771692777185d6b762efd5\">dehydrogenase</span> (G6PD) <span class=\"customMeta\" data-dictid=\"209b85faf71692777185767d43e3bd\">deficiency</span> is an <strong>X-linked genetic disorder </strong>that impairs <span class=\"customMeta\" data-dictid=\"248111ded81692777197946454db52\">red blood cell</span> protection against <span class=\"customMeta\" data-dictid=\"60d563fe241692777194203742bf5b\">oxidative</span> stress, leading to <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> when exposed to certain triggers like medications, foods, or infections.</li>\n\t<li>Primaquine generates <span class=\"customMeta\" data-dictid=\"092583d1b41692777197a506409267\">reactive</span> oxygen species (ROS), which normally would be neutralized by G6PD, but in <span class=\"customMeta\" data-dictid=\"96985248371692777188cfb38ca861\">G6PD</span> deficiency, <span class=\"customMeta\" data-dictid=\"60d563fe241692777194203742bf5b\">oxidative</span> damage accumulates, leading to <span class=\"customMeta\" data-dictid=\"d30ae941d516927771889351160b00\">hemolytic</span> <span class=\"customMeta\" data-dictid=\"53bee2a41216927771814d7ec3a67f\">anemia</span> in these individuals.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Mefloquine </strong><strong>(Option B)</strong> is another <span class=\"customMeta\" data-dictid=\"7f56a9f82e1692777181c7810a4c8b\">antimalarial</span> drug, it is generally not known to cause <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> in G6PD-deficient individuals.</p>\n\n<p> </p>\n\n<p><strong>Penicillin </strong><strong>(Option C) </strong>is an <span class=\"customMeta\" data-dictid=\"ff6b4f4d491692777181a02bad075e\">antibiotic</span> that is not typically associated with <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> in G6PD-deficient individuals.</p>\n\n<p> </p>\n\n<p><strong>Tetracycline</strong><strong> (Option D)</strong> is an antibiotic, and there is no significant association between <span class=\"customMeta\" data-dictid=\"8784b5a7ad16927772005323b514b8\">tetracycline</span> use and <span class=\"customMeta\" data-dictid=\"c2b082746716927771888f0933941d\">hemolysis</span> in G6PD-deficient individuals. It does not cause <span class=\"customMeta\" data-dictid=\"60d563fe241692777194203742bf5b\">oxidative</span> stress in red blood cells in the same way as drugs like primaquine.</p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What is the mechanism of action of dicumarol?",
      "choices": [
        {
          "id": 0,
          "text": "Activates antithrombin III"
        },
        {
          "id": 1,
          "text": "Inhibits vitamin K-dependent clotting factors"
        },
        {
          "id": 2,
          "text": "Inhibits tissue plasminogen activator"
        },
        {
          "id": 3,
          "text": "Inhibitor of factor Xa"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer B - Inhibits <span class=\"customMeta\" data-dictid=\"71c2092f15169277720243eb1590b0\">vitamin K</span> dependent <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">Clotting</span> factors</strong></p>\n\n<ul>\n\t<li><strong>Dicumarol (also known as Bishydroxycoumarin)</strong> inhibits <strong>vitamin K-dependent </strong>clotting factors, including factors II, VII, IX, and X.</li>\n\t<li>It inhibits the <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> <strong>VKOR (vitamin K <span class=\"customMeta\" data-dictid=\"29ca44bd601692777187c3d92d645b\">epoxide</span> reductase).</strong></li>\n\t<li>It has poor <span class=\"customMeta\" data-dictid=\"b3a647ce2516927771881427f56c1d\">gastrointestinal</span> tolerance.</li>\n\t<li>It's not preferred now.</li>\n</ul>\n\n<p><strong>Activates <span class=\"customMeta\" data-dictid=\"fa202015a216927771814a0dc268ba\">antithrombin</span> III (Option A): </strong>Heparin is an <span class=\"customMeta\" data-dictid=\"2f73e160ba1692777190d65065c95b\">indirect</span> <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> that activates <span class=\"customMeta\" data-dictid=\"fa202015a216927771814a0dc268ba\">antithrombin</span> III activity to <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> indirectly. <span class=\"customMeta\" data-dictid=\"90507489cc16927771867680354814\">Dicumarol</span> does not <span class=\"customMeta\" data-dictid=\"dddc752e1716927771807f985bb8bb\">activate</span> <span class=\"customMeta\" data-dictid=\"fa202015a216927771814a0dc268ba\">antithrombin</span> III.</p>\n\n<p><strong>Inhibits tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> (Option C): </strong>Epsilon Amino-Caproic Acid (EACA) is an anti-fibrinolytic drug that inhibits tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> and is used as an <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> for fibrinolytic. <span class=\"customMeta\" data-dictid=\"90507489cc16927771867680354814\">Dicumarol</span> does not <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> the action of the tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> activator.</p>\n\n<p><strong>Inhibitor of factor Xa (Option D):</strong> Apixaban, Rivaroxaban, Edoxaban, and <span class=\"customMeta\" data-dictid=\"1a9ec2a08a1692777182bf0fbfaf5f\">Betrixaban</span> are direct inhibitors of factor Xa. They are used in the treatment of <span class=\"customMeta\" data-dictid=\"7b6c3bb2611692777186e94c623ac9\">DVT</span> (deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis). <span class=\"customMeta\" data-dictid=\"90507489cc16927771867680354814\">Dicumarol</span> does not directly <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> factor Xa. Instead, it indirectly inhibits the production of factor Xa by inhibiting the production of vitamin K-dependent <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "The mechanism of action of tissue plasminogen activator is:",
      "choices": [
        {
          "id": 0,
          "text": "Inhibit extrinsic pathway"
        },
        {
          "id": 1,
          "text": "Inhibits platelet aggregation"
        },
        {
          "id": 2,
          "text": "Enhance fibrin degradation"
        },
        {
          "id": 3,
          "text": "Inhibit clot formation"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer C - Enhance <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> degradation</strong></p>\n\n<ul>\n\t<li>Tissue <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> <span class=\"customMeta\" data-dictid=\"a095f733351692777180a29940c98a\">activator</span> (tPA) is a naturally occurring <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> that converts <span class=\"customMeta\" data-dictid=\"bab1a0998e1692777195514ec82e5f\">plasminogen</span> to plasmin. <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">Plasmin</span> is responsible for breaking down <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> clots in the blood, which is the mechanism of action of tPA.</li>\n</ul>\n\n<div style=\"text-align:center\">\n<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"PPH007\" data-author=\"NA\" data-hash=\"11373\" data-license=\"NA\" data-source=\"NA\" data-tags=\"April2025\" height=\"445\" src=\"https://image.prepladder.com/notes/UMCrmvHcypVLhWedSk7X1745908352.png\" width=\"600\" />\n<figcaption>{{caption_text}}</figcaption>\n</figure>\n</div>\n\n<p><strong>Inhibit <span class=\"customMeta\" data-dictid=\"810de80cac1692777187a436b4315b\">extrinsic</span> <span class=\"customMeta\" data-dictid=\"3aa5abc2fa169277719488e088076d\">pathway</span> (Option A): </strong>Tissue factor <span class=\"customMeta\" data-dictid=\"3aa5abc2fa169277719488e088076d\">pathway</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> (TFPI) is the <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> of the <span class=\"customMeta\" data-dictid=\"810de80cac1692777187a436b4315b\">extrinsic</span> <span class=\"customMeta\" data-dictid=\"3aa5abc2fa169277719488e088076d\">pathway</span> of coagulation. It inhibits the formation of factor Xa and thus prevents <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> formation.</p>\n\n<p><strong>Inhibits <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"a00e90be0416927771803afbbf099b\">aggregation</span> (Option B): </strong>Antiplatelet agents like <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> and clopidogrel <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"a00e90be0416927771803afbbf099b\">aggregation</span> and prevent the formation of blood clots.</p>\n\n<p><strong>Inhibit <span class=\"customMeta\" data-dictid=\"5e0b40993316927771844dbf382689\">clot</span> formation (Option D): </strong>Anticoagulant drugs like <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> and <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> the formation of blood clots by <span class=\"customMeta\" data-dictid=\"653140d1dc16927771903445309f4e\">interfering</span> with the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> <span class=\"customMeta\" data-dictid=\"6826aa04ef16927771833336e53730\">cascade</span> at different points. They do not directly break down existing clots.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/notes/UMCrmvHcypVLhWedSk7X1745908352.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A first-trimester pregnant female has DVT and needs anticoagulation. Which of the following anticoagulants is preferred?",
      "choices": [
        {
          "id": 0,
          "text": "Enoxaparin"
        },
        {
          "id": 1,
          "text": "Clopidogrel"
        },
        {
          "id": 2,
          "text": "Betrixaban"
        },
        {
          "id": 3,
          "text": "Warfarin"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer: B) Enoxaparin</strong></p>\n\n<p><strong>Explanation: </strong></p>\n\n<ul>\n\t<li><strong>Enoxaparin </strong>is a<strong> low <span class=\"customMeta\" data-dictid=\"b2df2436bf1692777193d90e9c0132\">molecular weight</span> <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> (LMWH) </strong>that inhibits <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors 10 and 2 (10 >> 2), which is the preferred <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> during pregnancy for the treatment of DVT.</li>\n\t<li><strong>LMWHs</strong> like enoxaparin do not cross the <strong>placenta</strong>, making them safe for use in pregnant women.</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Anticoagulants in pregnancy</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Gestational period </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Anticoagulants preferred </strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>0-12 weeks </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>LMW/ULMW heparin</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>12-36 weeks</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>LMW/ULMW heparin</li>\n\t\t\t\t<li>As <span class=\"customMeta\" data-dictid=\"9bd7909f881692777194ca6ea37a0c\">organogenesis</span> is completed, <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">Warfarin</span> may be used only in cases of patients with mechanical <span class=\"customMeta\" data-dictid=\"c936e2cd131692777196b1d877f678\">prosthetic</span> valves</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>36 weeks till delivery </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>LMW/ULMW heparin</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>During delivery </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>No <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> is used due to the risk of <span class=\"customMeta\" data-dictid=\"3d885759d516927771966b84bfa470\">postpartum</span> hemorrhage</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>During <span class=\"customMeta\" data-dictid=\"4abd8094e51692777191b1eb073735\">lactation</span> </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Warfarin is preferred over heparin</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><strong>Clopidogrel </strong><strong>(Option B)</strong><strong> </strong>is an <strong>antiplatelet agent</strong>, not an anticoagulant. It is useful in the prevention of arterial thromboembolism, but it is not typically used for the treatment of <strong>DVT</strong> in pregnancy.</p>\n\n<p><strong>Betrixaban</strong><strong> (Option C) </strong>is a <strong>direct factor Xa inhibitor</strong><strong>.</strong> It is not used in pregnancy.</p>\n\n<p><br />\n<strong>Warfarin</strong><strong> (Option D)</strong><strong> </strong>is contraindicated in the <strong>first <span class=\"customMeta\" data-dictid=\"2c20f0f1dd169277720029d29458d5\">trimester</span> of pregnancy</strong> as it is <strong>teratogenic</strong>, leading to <strong>Congenital <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> syndrome.</strong></p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which among the following anticoagulants requires aPTT monitoring?",
      "choices": [
        {
          "id": 0,
          "text": "Lepirudin"
        },
        {
          "id": 1,
          "text": "Enoxaparin"
        },
        {
          "id": 2,
          "text": "Dabigatran"
        },
        {
          "id": 3,
          "text": "Apixaban"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - Lepirudin:</strong></p>\n\n<ul>\n\t<li>Lepirudin is a <span class=\"customMeta\" data-dictid=\"b566321fe8169277719716b1cf4df0\">recombinant</span> <span class=\"customMeta\" data-dictid=\"a1b06f401f1692777203a53393ba98\">form</span> of hirudin. Desirudin and <span class=\"customMeta\" data-dictid=\"27c736de691692777191197a0890ed\">lepirudin</span> are medications used to treat <span class=\"customMeta\" data-dictid=\"3e745919391692777200fae21b7251\">thrombosis</span> in patients with heparin-induced thrombocytopenia. They are eliminated by the kidneys, with a <span class=\"customMeta\" data-dictid=\"082d1526db1692777188311b6eef04\">half-life</span> of about 2 hours after <span class=\"customMeta\" data-dictid=\"d446e62c6c1692777199896fc1d4b9\">subcutaneous</span> administration and approximately 10 minutes after <span class=\"customMeta\" data-dictid=\"27b78a96071692777190f4dfb93430\">intravenous</span> infusion. Caution should be exercised when using these drugs in patients with decreased <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> function, and daily monitoring of <span class=\"customMeta\" data-dictid=\"1ffaec13de169277719828374cfda0\">serum</span> <span class=\"customMeta\" data-dictid=\"2ead0fd0301692777185187bd72768\">creatinine</span> and <span class=\"customMeta\" data-dictid=\"c91819a65716927771810b66ea6869\">aPTT</span> levels is recommended.</li>\n</ul>\n\n<p> </p>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option B - Enoxaparin:</strong> This is a low <span class=\"customMeta\" data-dictid=\"b2df2436bf1692777193d90e9c0132\">molecular weight</span> <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> (LMWH). LMWH usually produces a predictable <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> response, so routine monitoring is not needed. However, patients with <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> impairment, obesity, pregnancy, and children may require monitoring using an anti-factor Xa <span class=\"customMeta\" data-dictid=\"fc026ff6d81692777182835f6de6df\">assay</span> due to potential variations in the drug's effects.</p>\n\n<p><strong>Option C - Dabigatran:</strong> While dabigatran prolongs the aPTT, routine monitoring is not required due to its predictable <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> response at fixed doses. <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">Thrombin</span> time is too sensitive for monitoring dabigatran, and a diluted <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> time <span class=\"customMeta\" data-dictid=\"fc026ff6d81692777182835f6de6df\">assay</span> has been developed for quantifying <span class=\"customMeta\" data-dictid=\"a0e40688fa169277719572bdb48c92\">plasma</span> dabigatran concentrations, but these are not routinely used.</p>\n\n<p><strong>Option D - Apixaban: </strong>This is an oral direct factor Xa inhibitor. <span class=\"customMeta\" data-dictid=\"bd0e99d93a169277718152523f2534\">Apixaban</span> is given in fixed doses and does not require routine <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> monitoring. The drugs affect the PT more than the aPTT, but the PT does not reliably measure their <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> activity. Anti-factor Xa assays can measure drug levels. It's important to assess <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> function at least yearly in patients taking oral factor Xa inhibitors or more frequently in patients with <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> dysfunction.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What is the mechanism of action (MOA) of Rivaroxaban?",
      "choices": [
        {
          "id": 0,
          "text": "Inhibition of thrombin (Factor IIa)"
        },
        {
          "id": 1,
          "text": "Inhibition of Factor Xa"
        },
        {
          "id": 2,
          "text": "Activation of antithrombin III"
        },
        {
          "id": 3,
          "text": "Inhibition of platelet aggregation"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) <span class=\"customMeta\" data-dictid=\"f03ca2d2a716927771901227bc175a\">Inhibition</span> of Factor Xa</strong></p>\n\n<p><strong>Explanation: </strong></p>\n\n<ul>\n\t<li><strong>Rivaroxaban</strong> is an<strong> oral factor Xa inhibitor.</strong> It works by <strong>inhibiting factor Xa</strong>, which is an <strong>important component in the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> cascade</strong>.</li>\n\t<li>It<strong> </strong>is used for various indications, including <strong>prevention and treatment of deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis, <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> embolism, and prevention of stroke and <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> <span class=\"customMeta\" data-dictid=\"1c07a1135f1692777187f547678386\">embolism</span> in patients with atrial fibrillation.</strong></li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Type</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Mechanism of Action</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Drugs</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">Thrombin</span> Inhibitors</strong></p>\n\t\t\t</td>\n\t\t\t<td rowspan=\"2\" style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p>Inhibit <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> (factor IIa) directly without cofactors.</p>\n\n\t\t\t<p><strong>(Option A) </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Hirudin derivatives: </strong>Hirudin,<strong> Lepirudin.</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Non-hirudin (Synthetic):</strong> Argatroban, Bivalirudin.</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td rowspan=\"3\" style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Indirect <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">Thrombin</span> Inhibitors</strong></p>\n\t\t\t</td>\n\t\t\t<td rowspan=\"3\" style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p>Enhance <span class=\"customMeta\" data-dictid=\"fa202015a216927771814a0dc268ba\">antithrombin</span> III activity to <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> indirectly.</p>\n\n\t\t\t<p><strong>(Option C)</strong></p>\n\n\t\t\t<p> </p>\n\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Unfractionated Heparin: Heparin</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Low Molecular Weight Heparin (LMWH):</strong> <strong>Enoxaparin,</strong> Dalteparin, Tinzaparin</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p><strong>Ultra Low Molecular Weight Heparin (ULMWH):</strong> <strong>Fondaparinux,</strong> Idraparinux, Danaparoid (not commonly used)</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><strong>Inhibition of <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"a00e90be0416927771803afbbf099b\">aggregation</span> (Option D): </strong>Platelet <span class=\"customMeta\" data-dictid=\"a00e90be0416927771803afbbf099b\">aggregation</span> is primarily mediated by <strong>platelet receptors (like the ADP <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> or <span class=\"customMeta\" data-dictid=\"96309dcb1c169277720072ad555473\">thromboxane</span> A2), </strong>and drugs that <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"a00e90be0416927771803afbbf099b\">aggregation</span> include <strong>aspirin and P2Y12 inhibitors (like clopidogrel). </strong>Rivaroxaban works on the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> <span class=\"customMeta\" data-dictid=\"6826aa04ef16927771833336e53730\">cascade</span> by inhibiting Factor Xa and not through <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> inhibition.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following drugs is beneficial in reducing the painful crisis of sickle cell anemia?",
      "choices": [
        {
          "id": 0,
          "text": "Methionine"
        },
        {
          "id": 1,
          "text": "Hydroxyurea"
        },
        {
          "id": 2,
          "text": "Methotrexate + Leucovorin"
        },
        {
          "id": 3,
          "text": "Eltrombopag"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer B - Hydroxyurea</strong></p>\n\n<ul>\n\t<li>Hydroxyurea is the <strong>drug of choice</strong>, it works by increasing <span class=\"customMeta\" data-dictid=\"f375a3584316927772020efa386e3e\">fetal</span> <span class=\"customMeta\" data-dictid=\"ad2073fe6716927771885f3c1ec652\">hemoglobin</span> (HbF) levels, which helps reduce the frequency of sickle cell crises.</li>\n</ul>\n\n<p><strong>Mechanism of Action:</strong> <span class=\"customMeta\" data-dictid=\"ac923489f3169277718998b7f862df\">Hydroxyurea</span> blocks the conversion of ribonucleotides to deoxyribonucleotides by inhibiting the <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> <span class=\"customMeta\" data-dictid=\"9d1ffb84a81692777197c499f3f4ec\">ribonucleoside</span> <span class=\"customMeta\" data-dictid=\"e85b7f998a1692777186537b5aeefa\">diphosphate</span> <span class=\"customMeta\" data-dictid=\"6afb2667fe16927771975a8db1378b\">reductase</span> (RNR), thereby <span class=\"customMeta\" data-dictid=\"653140d1dc16927771903445309f4e\">interfering</span> with DNA synthesis.</p>\n\n<p><strong>Other Uses of Hydroxyurea:</strong></p>\n\n<ul>\n\t<li>Chronic <span class=\"customMeta\" data-dictid=\"da88d7f2211692777193037caba514\">myeloid</span> leukemia,</li>\n\t<li>Psoriasis,</li>\n\t<li>Polycythemia vera,</li>\n\t<li>Occasionally used in some solid tumors as a <span class=\"customMeta\" data-dictid=\"e60f8af4341692777197f6c2c5ecd5\">radiosensitizer</span> before radiotherapy.</li>\n</ul>\n\n<p><strong>Dosage of Hydroxyurea:</strong></p>\n\n<ul>\n\t<li>Daily dose: 20-30 mg/kg</li>\n\t<li>Twice weekly dose: 80 mg/kg</li>\n</ul>\n\n<p><strong>Methionine (Option A)</strong> is incorrect as this drug is of no use in preventing painful vaso-occlusive crises and preventing long-term complications in sickle cell anemia.</p>\n\n<p><strong>Methotrexate + <span class=\"customMeta\" data-dictid=\"63c94f3806169277719134c870bb52\">Leucovorin</span> (Option C)</strong> is incorrect as this drug is of no use in preventing painful vaso-occlusive crises and preventing long-term complications in sickle cell anemia.</p>\n\n<p><strong>Eltrombopag (Option D)</strong> is incorrect as this drug is of no use in preventing painful vaso-occlusive crises and preventing long-term complications in sickle cell anemia.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "In a 35-year-old female with sickle cell disease who presents with unprovoked pain in her extremities and torso, thromboembolic events are suspected. What is the initial medication that should be administered for prophylaxis of thromboembolic events in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "LMWH"
        },
        {
          "id": 1,
          "text": "Warfarin"
        },
        {
          "id": 2,
          "text": "Aspirin"
        },
        {
          "id": 3,
          "text": "Dabigatran"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - LMWH:</strong></p>\n\n<ul>\n\t<li>LMWH (Low <span class=\"customMeta\" data-dictid=\"b2df2436bf1692777193d90e9c0132\">Molecular Weight</span> Heparin): LMWH, such as enoxaparin, is often used as the initial medication for <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> of thromboembolic events in patients with sickle cell disease. It has both <span class=\"customMeta\" data-dictid=\"e684325d851692777196af9e64013b\">preventive</span> and immediate <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> effects, making it suitable for both long-term <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> and initial management of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> thromboembolic events.</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option B -</strong><strong> Warfarin</strong><strong>:</strong> <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">Warfarin</span> is an oral <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> medication used for long-term <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> against blood clots. However, it takes some time to reach its full <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> effect and is not typically the first choice for immediate management of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> events.</p>\n\n<p><strong>Option C -</strong><strong> Aspirin:</strong> <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">Aspirin</span> is an <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> medication that helps prevent the formation of blood clots, but it may not be the first-line choice for thromboembolic event <span class=\"customMeta\" data-dictid=\"bc36e9b9381692777196b5f9a2f79c\">prophylaxis</span> in patients with sickle cell disease. It is more commonly used in other conditions, such as <span class=\"customMeta\" data-dictid=\"e2b5f013011692777183ea1b11ed9c\">cardiovascular</span> disease.</p>\n\n<p><strong>Option D -</strong><strong> Dabigatran:</strong> Dabigatran is one of the newer oral <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> medications used for long-term prophylaxis. It is not usually the initial choice for immediate management of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> thromboembolic events.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What is the most useful drug to treat Doxorubicin-induced cardiotoxicity?",
      "choices": [
        {
          "id": 0,
          "text": "Aprepitant"
        },
        {
          "id": 1,
          "text": "Deferoxamine"
        },
        {
          "id": 2,
          "text": "Amifostine"
        },
        {
          "id": 3,
          "text": "Dexrazoxane"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer: D) Dexrazoxane</strong></p>\n\n<p><strong>Explanation: </strong></p>\n\n<ul>\n\t<li><strong>Dexrazoxane</strong> is used for the treatment of <strong>Doxorubicin-induced cardiotoxicity.</strong></li>\n\t<li>It is a cardioprotective, iron-chelating agent.</li>\n\t<li>It is used to prevent <span class=\"customMeta\" data-dictid=\"5dc2899332169277718350ff2207b9\">cardiotoxicity</span> caused by the anthracyclines <span class=\"customMeta\" data-dictid=\"845ffca50f1692777186d5ed72e81a\">doxorubicin</span> and daunorubicin.</li>\n\t<li>It may also prevent anthracycline-derived DNA damage by interacting with <strong>topoisomerase II in <span class=\"customMeta\" data-dictid=\"e1fb96fd2416927771830dfed40e14\">cardiac</span> cells.</strong></li>\n</ul>\n\n<p><strong>Aprepitant (Option A) </strong>is a <span class=\"customMeta\" data-dictid=\"11176bbab41692777193a0b9137a63\">neurokinin</span> 1 <span class=\"customMeta\" data-dictid=\"adecdf9cb2169277718363b8a0e491\">blocker</span> used for late CINV (Chemotherapy-induced <span class=\"customMeta\" data-dictid=\"9a8412e39e1692777193c550a5dbb4\">Nausea</span> and Vomiting).</p>\n\n<p><strong>Deferoxamine (Option B)</strong> is incorrect as it is an iron chelator.</p>\n\n<p><strong>Amifostine (Option C)</strong> is incorrect as it is used to prevent <span class=\"customMeta\" data-dictid=\"ca71207b36169277718438d09cbda0\">cisplatin</span> nephrotoxicity.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 25-year-old male patient presents with several purpuric skin lesions and is diagnosed with idiopathic thrombocytopenic purpura. Which of the following tyrosine kinase inhibitors can be used in this condition?",
      "choices": [
        {
          "id": 0,
          "text": "Oprelvekin"
        },
        {
          "id": 1,
          "text": "Fostamatinib"
        },
        {
          "id": 2,
          "text": "Eltrombopag"
        },
        {
          "id": 3,
          "text": "Romiplostim"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Answer: B) Fostamatinib</strong></p>\n\n<ul>\n\t<li><strong>Fostamatinib </strong>is approved for the treatment of <span class=\"customMeta\" data-dictid=\"4acddc3cf5169277718996440e2e14\">idiopathic</span> thrombocytopenic purpura.</li>\n\t<li>It is a Tyrosine <span class=\"customMeta\" data-dictid=\"9863da498e1692777190e1c6515b48\">kinase</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> used in the management of chronic <span class=\"customMeta\" data-dictid=\"4acddc3cf5169277718996440e2e14\">idiopathic</span> thrombocytopenic purpura.</li>\n\t<li>The first line of drugs used to manage this condition is steroids. Fostamatinib is only used in patients who do not respond to first-line therapy.</li>\n</ul>\n\n<p><strong>Oprelvekin (Option A)</strong> is incorrect because it is an <span class=\"customMeta\" data-dictid=\"87906574d616927771895ad1e8ffcc\">IL</span> 11 <span class=\"customMeta\" data-dictid=\"22e0051a181692777181872183edb2\">analogue</span> and it is used in <span class=\"customMeta\" data-dictid=\"fc28c74bb716927772003aee4aa43c\">thrombocytopenia</span> <span class=\"customMeta\" data-dictid=\"f3063c1d8b169277719018bf869980\">induced</span> due to anti-cancer drug therapy.</p>\n\n<p><strong>Eltrombopag (Option C)</strong> is incorrect as it is a <span class=\"customMeta\" data-dictid=\"b084a2ed0d1692777200e64e4a9b54\">thrombopoietin</span> <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> <span class=\"customMeta\" data-dictid=\"7d8d28cda71692777180c89a3c86ce\">agonist</span> used in <span class=\"customMeta\" data-dictid=\"4acddc3cf5169277718996440e2e14\">idiopathic</span> thrombocytopenic purpura.</p>\n\n<p><strong>Romiplostim (Option D)</strong> ) is incorrect as it is a <span class=\"customMeta\" data-dictid=\"b084a2ed0d1692777200e64e4a9b54\">thrombopoietin</span> <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> <span class=\"customMeta\" data-dictid=\"7d8d28cda71692777180c89a3c86ce\">agonist</span> used for the treatment of <span class=\"customMeta\" data-dictid=\"4acddc3cf5169277718996440e2e14\">idiopathic</span> thrombocytopenic <span class=\"customMeta\" data-dictid=\"0acd34c758169277719644923511e5\">purpura</span> (ITP).</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A young female comes to the emergency department after consuming 100 aspirin tablets. What should be the next step in management?",
      "choices": [
        {
          "id": 0,
          "text": "N-acetyl cysteine to replenish glutathione stores"
        },
        {
          "id": 1,
          "text": "Pralidoxime"
        },
        {
          "id": 2,
          "text": "Glucagon to control bradycardia and hypoglycemia"
        },
        {
          "id": 3,
          "text": "Give sodium bicarbonate to alkalize urine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Answer D - Give sodium <span class=\"customMeta\" data-dictid=\"2311c3b4ac16927771831d4c919043\">bicarbonate</span> to <span class=\"customMeta\" data-dictid=\"11dc8d57a01692777181568b2b8461\">alkalize</span> urine</strong></p>\n\n<p>The given scenario is a case of <strong>aspirin toxicity</strong> in which the primary treatment is to give <strong>sodium bicarbonate</strong> in order to <span class=\"customMeta\" data-dictid=\"11dc8d57a01692777181568b2b8461\">alkalize</span> the urine.</p>\n\n<ul>\n\t<li>It is an <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> medication that irreversibly inhibits COX-1, thereby preventing <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> aggregation.</li>\n\t<li>Aspirin stimulates the brain's <span class=\"customMeta\" data-dictid=\"cfad80a0f716927771979aae100f95\">respiratory</span> center, causing <span class=\"customMeta\" data-dictid=\"e07ff4a5ce1692777189b9e95326f3\">hyperventilation</span> (↓CO<sub>2</sub> levels) and <strong>respiratory alkalosis.</strong></li>\n\t<li>The kidneys <span class=\"customMeta\" data-dictid=\"350d30aa5316927771874442f8874c\">excrete</span> more <span class=\"customMeta\" data-dictid=\"2311c3b4ac16927771831d4c919043\">bicarbonate</span> to counteract <span class=\"customMeta\" data-dictid=\"cfad80a0f716927771979aae100f95\">respiratory</span> alkalosis, resulting in <span class=\"customMeta\" data-dictid=\"d92cbff33316927771927b4de10a5b\">metabolic</span> <span class=\"customMeta\" data-dictid=\"6caf3a39f416927771807e122b9032\">acidosis</span> <strong>(Compensatory <span class=\"customMeta\" data-dictid=\"d92cbff33316927771927b4de10a5b\">metabolic</span> acidosis).</strong> High doses of <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> can disrupt <span class=\"customMeta\" data-dictid=\"60d563fe241692777194203742bf5b\">oxidative</span> <span class=\"customMeta\" data-dictid=\"619ba5e99c16927771958308fb8687\">phosphorylation</span> and <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> function, exacerbating <span class=\"customMeta\" data-dictid=\"d92cbff33316927771927b4de10a5b\">metabolic</span> acidosis.</li>\n</ul>\n\n<p><strong>Dosage and Toxicity:</strong></p>\n\n<ul>\n\t<li><strong>Therapeutic Dose: </strong>3-5 g/day can cause <strong>mild chronic <span class=\"customMeta\" data-dictid=\"d3323d4b271692777200122ea879e5\">toxicity</span> (salicylism).</strong></li>\n\t<li>Toxic Dose: Acute <span class=\"customMeta\" data-dictid=\"eba893313f16927771906290ce7e79\">ingestion</span> of 10-30 g in adults can be lethal, with much lower doses (4 mL of <span class=\"customMeta\" data-dictid=\"bc09155adc169277719248f9543785\">methyl</span> salicylate) posing a significant risk in children</li>\n</ul>\n\n<p><strong>Clinical presentation:</strong></p>\n\n<ul>\n\t<li><strong>Salicylism: </strong>Headache, dizziness, tinnitus, <strong>reversible hearing and vision impairment, </strong>drowsiness, vomiting, hyperventilation, <span class=\"customMeta\" data-dictid=\"2e0552462e16927771871413861fb7\">electrolyte</span> imbalance</li>\n\t<li>Severe toxicity: Dehydration, high tone deafness, confusion, petechial haemorrhages, hyperpyrexia, seizures, hypoglycemia, psychosis, coma</li>\n</ul>\n\n<p><strong>Management:</strong></p>\n\n<ul>\n\t<li>Treatment is supportive and includes <span class=\"customMeta\" data-dictid=\"12347b15191692777188bc86d226e1\">gastric</span> lavage, <span class=\"customMeta\" data-dictid=\"92a52a7756169277718538d58fe1a9\">correction</span> of <span class=\"customMeta\" data-dictid=\"d92cbff33316927771927b4de10a5b\">metabolic</span> acidosis, vitamin K supplements and <span class=\"customMeta\" data-dictid=\"0b72f5e96b16927772018dec8a87e2\">urinary</span> <span class=\"customMeta\" data-dictid=\"91f580d150169277718171ee6ba559\">alkalinization</span> with <span class=\"customMeta\" data-dictid=\"27b78a96071692777190f4dfb93430\">intravenous</span> sodium <span class=\"customMeta\" data-dictid=\"2311c3b4ac16927771831d4c919043\">bicarbonate</span> to enhance <span class=\"customMeta\" data-dictid=\"ac91ef7dac16927771985192826d28\">salicylate</span> excretion. In severe cases, <span class=\"customMeta\" data-dictid=\"6ba3fb0ce51692777188eaf7843351\">hemodialysis</span> may be necessary.</li>\n</ul>\n\n<div style=\"text-align:center\">\n<figure class=\"caption_element\" style=\"display:inline-block\"><img alt=\"\" data-author=\"NA\" data-hash=\"\" data-license=\"NA\" data-source=\"NA\" data-tags=\"\" height=\"408\" src=\"https://image.prepladder.com/content/e2Rd6RkF25hcMx3r0Yvh1745303240.png\" width=\"500\" />\n<figcaption>{{caption_text}}</figcaption>\n</figure>\n</div>\n\n<p><strong>N-acetyl <span class=\"customMeta\" data-dictid=\"dabfa103741692777185dac756c49b\">cysteine</span> to replenish <span class=\"customMeta\" data-dictid=\"f945849e691692777188ad7ce5b5e2\">glutathione</span> stores (Option A) </strong>is not indicated in the management of <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> overdose. It is used as an <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> for <span class=\"customMeta\" data-dictid=\"95b7c54ee116927771809963c4ee14\">acetaminophen</span> overdose, which can cause liver <span class=\"customMeta\" data-dictid=\"d3323d4b271692777200122ea879e5\">toxicity</span> by depleting <span class=\"customMeta\" data-dictid=\"f945849e691692777188ad7ce5b5e2\">glutathione</span> stores. <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">Aspirin</span> <span class=\"customMeta\" data-dictid=\"3f4eecb1c6169277719459c801fb19\">overdose</span> does not cause <span class=\"customMeta\" data-dictid=\"f945849e691692777188ad7ce5b5e2\">glutathione</span> depletion, so N-acetyl <span class=\"customMeta\" data-dictid=\"dabfa103741692777185dac756c49b\">cysteine</span> is not useful in this situation.</p>\n\n<p><strong>Pralidoxime (Option B) </strong>is not indicated in the management of <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> overdose. Pralidosime is an <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> for <span class=\"customMeta\" data-dictid=\"505a21f8451692777194a113951c68\">organophosphate</span> poisoning, which can cause <span class=\"customMeta\" data-dictid=\"8656dac49a16927771846b41f8cf19\">cholinergic</span> <span class=\"customMeta\" data-dictid=\"d3323d4b271692777200122ea879e5\">toxicity</span> by inhibiting <span class=\"customMeta\" data-dictid=\"63b92227451692777180db3901b72f\">acetylcholinesterase</span> activity. <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">Aspirin</span> <span class=\"customMeta\" data-dictid=\"3f4eecb1c6169277719459c801fb19\">overdose</span> does not cause <span class=\"customMeta\" data-dictid=\"8656dac49a16927771846b41f8cf19\">cholinergic</span> toxicity, so this option is not used here.</p>\n\n<p><strong>Glucagon to control <span class=\"customMeta\" data-dictid=\"c933e533971692777183b764d960d0\">bradycardia</span> and <span class=\"customMeta\" data-dictid=\"78c658d4ed1692777189098c7544b9\">hypoglycemia</span> (Option C): </strong>Glucagon is not indicated in the management of <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">aspirin</span> overdose. Glucagon is used as an <span class=\"customMeta\" data-dictid=\"5e612ce1381692777181adc76f11e6\">antidote</span> to beta-blocker toxicity</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [
        "https://image.prepladder.com/content/e2Rd6RkF25hcMx3r0Yvh1745303240.png"
      ],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A patient with a malignancy is undergoing chemotherapy; his platelet counts were reduced during the previous cycle of chemotherapy. What time will you give this to prevent/treat this condition?",
      "choices": [
        {
          "id": 0,
          "text": "Oprelvekin (IL-11)"
        },
        {
          "id": 1,
          "text": "Filgrastim"
        },
        {
          "id": 2,
          "text": "Erythropoietin"
        },
        {
          "id": 3,
          "text": "Amifostine"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Answer A - <span class=\"customMeta\" data-dictid=\"73e490ea3f1692777194b3e2311f72\">Oprelvekin</span> (IL-11)</strong></p>\n\n<ul>\n\t<li><strong>Oprelvekin (IL-11) </strong>is a medication used to stimulate <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> production in patients who have undergone chemotherapy.</li>\n\t<li>It works by stimulating the production of megakaryocytes, which are the cells that produce platelets.</li>\n\t<li>It is approved for use in patients with <strong>chemotherapy-induced <span class=\"customMeta\" data-dictid=\"fc28c74bb716927772003aee4aa43c\">thrombocytopenia</span> (CIT)</strong>, a condition characterized by a low <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> count caused by chemotherapy.</li>\n</ul>\n\n<p><strong>Filgrastim (Option B) </strong>is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy. It works by stimulating the <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> to produce more white blood cells, which can help to prevent infections. While low <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> counts can be a <span class=\"customMeta\" data-dictid=\"79506a117416927771988bbe7a8302\">side effect</span> of chemotherapy, <span class=\"customMeta\" data-dictid=\"961cab02fe1692777202b03db9637d\">filgrastim</span> is not indicated for treating thrombocytopenia.</p>\n\n<p><strong>Erythropoietin (Option C) </strong>is a medication that stimulates <span class=\"customMeta\" data-dictid=\"248111ded81692777197946454db52\">red blood cell</span> production in patients with anemia. It is not indicated for the treatment of thrombocytopenia.</p>\n\n<p><strong>Amifostine (Option D) </strong>is a medication used to protect healthy cells from the toxic effects of chemotherapy. It does not stimulate the production of platelets and is not indicated for the treatment of thrombocytopenia.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A patient on anti-cancer therapy developed an infection. Blood analysis revealed neutropenia. Which of the following drugs is likely to be effective in this patient?",
      "choices": [
        {
          "id": 0,
          "text": "Romiplostim"
        },
        {
          "id": 1,
          "text": "Oprelvekin"
        },
        {
          "id": 2,
          "text": "Filgrastim"
        },
        {
          "id": 3,
          "text": "Epoetin alfa"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Answer C - <span class=\"customMeta\" data-dictid=\"961cab02fe1692777202b03db9637d\">Filgrastim</span> </strong></p>\n\n<ul>\n\t<li><strong>Filgrastim </strong>is likely to be effective for <span class=\"customMeta\" data-dictid=\"3925bbe5df1692777193bd03c159a8\">neutropenia</span> in a patient on anti-cancer therapy.</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Class </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:1px solid black; vertical-align:top\">\n\t\t\t<p>Recombinant human <span class=\"customMeta\" data-dictid=\"a5e951c6221692777188d09fdd7e1a\">G-CSF</span> (Granulocyte colony-stimulating factor)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Mechanism of action </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>Stimulates colony-forming unit (CFU) granulocytes to increase <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> production.</li>\n\t\t\t\t<li>Enhances <span class=\"customMeta\" data-dictid=\"b68a8f1b37169277719547f1cfda59\">phagocytic</span> and cytotoxic activities of neutrophils.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:1px solid black; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<p style=\"text-align: center;\"><strong>Uses </strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid black; border-left:none; border-right:1px solid black; border-top:none; vertical-align:top\">\n\t\t\t<ul>\n\t\t\t\t<li>To treat severe <span class=\"customMeta\" data-dictid=\"3925bbe5df1692777193bd03c159a8\">neutropenia</span> (after <span class=\"customMeta\" data-dictid=\"0a266da66816927771824d58668832\">autologous</span> <span class=\"customMeta\" data-dictid=\"d2e0ab499c169277718886ab5a46bf\">hematopoietic</span> stem cell transplantation, high-dose cancer chemotherapy, <span class=\"customMeta\" data-dictid=\"488a4efe7d16927771840c9e29f164\">congenital</span> neutropenias, and patients with AIDS receiving zidovudine)</li>\n\t\t\t\t<li>Used in patients undergoing <span class=\"customMeta\" data-dictid=\"255674f3271692777195c172d86daf\">peripheral</span> blood stem cell collection for stem cell transplantation.</li>\n\t\t\t</ul>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p><strong>Romiplostim (Option A)</strong> is a <span class=\"customMeta\" data-dictid=\"b084a2ed0d1692777200e64e4a9b54\">thrombopoietin</span> <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> <span class=\"customMeta\" data-dictid=\"7d8d28cda71692777180c89a3c86ce\">agonist</span> that binds to <span class=\"customMeta\" data-dictid=\"b084a2ed0d1692777200e64e4a9b54\">thrombopoietin</span> receptors on <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> megakaryocytes and stimulates the production of platelets. It is used to treat thrombocytopenia.</p>\n\n<p><strong>Oprelvekin (Option B)</strong> binds to <span class=\"customMeta\" data-dictid=\"b084a2ed0d1692777200e64e4a9b54\">thrombopoietin</span> receptors on <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> megakaryocytes, stimulates the production of megakaryocytes, and is used to treat thrombocytopenia.</p>\n\n<p><strong>Epoetin alfa (Option D)</strong>, also known as Erythropoietin, is produced by <span class=\"customMeta\" data-dictid=\"ce12dc160c1692777195473ab2cc21\">peritubular</span> cells of the <span class=\"customMeta\" data-dictid=\"4aa6035df41692777190b41d4a1583\">kidney</span> and is essential for normal erythropoiesis. It stimulates <span class=\"customMeta\" data-dictid=\"248111ded81692777197946454db52\">red blood cell</span> production and is ineffective in treating neutropenia.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "LMWH is given by which route?",
      "choices": [
        {
          "id": 0,
          "text": "Intravenous"
        },
        {
          "id": 1,
          "text": "Subcutaneous"
        },
        {
          "id": 2,
          "text": "Intramuscular"
        },
        {
          "id": 3,
          "text": "Intradermal"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Option B - Subcutaneous:</strong></p>\n\n<ul>\n\t<li>\n\t<p>LMWH (Low <span class=\"customMeta\" data-dictid=\"b2df2436bf1692777193d90e9c0132\">Molecular Weight</span> Heparin) is typically administered via the <span class=\"customMeta\" data-dictid=\"d446e62c6c1692777199896fc1d4b9\">subcutaneous</span> route. <span class=\"customMeta\" data-dictid=\"d446e62c6c1692777199896fc1d4b9\">Subcutaneous</span> administration involves injecting the medication into the <span class=\"customMeta\" data-dictid=\"bc6cd9a9f9169277720261812ea113\">fatty</span> tissue layer just beneath the skin. This route allows for slow and sustained <span class=\"customMeta\" data-dictid=\"5fcb9396d1169277718069dd7fa788\">absorption</span> of the medication into the bloodstream. LMWH is specifically formulated for <span class=\"customMeta\" data-dictid=\"d446e62c6c1692777199896fc1d4b9\">subcutaneous</span> use and is available in pre-filled syringes or cartridges.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A</strong> <strong>- <span class=\"customMeta\" data-dictid=\"27b78a96071692777190f4dfb93430\">Intravenous</span> (IV): </strong>LMWH is not typically administered intravenously. Regular <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> can be given intravenously.</p>\n\n<p><strong>Option C - <span class=\"customMeta\" data-dictid=\"8a99f9c37f16927771902daa814697\">Intramuscular</span> (IM):</strong> LMWH is not administered intramuscularly as it can cause pain, <span class=\"customMeta\" data-dictid=\"832849414c1692777188491f77bb5f\">hematoma</span> formation, and unpredictable absorption.</p>\n\n<p><strong>Option D - <span class=\"customMeta\" data-dictid=\"de8b4033c51692777190aaeca3d6bc\">Intradermal</span> (ID): </strong>LMWH is not administered intradermally as it is not intended for local effects and may not be well absorbed through the skin.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the options listed below is an oral medication that directly inhibits thrombin?",
      "choices": [
        {
          "id": 0,
          "text": "Dabigatran"
        },
        {
          "id": 1,
          "text": "Rivaroxaban"
        },
        {
          "id": 2,
          "text": "Warfarin"
        },
        {
          "id": 3,
          "text": "Lepirudin"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - Dabigatran:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Dabigatran is an oral direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> and is the correct answer to the question. It belongs to a class of medications called non-vitamin K <span class=\"customMeta\" data-dictid=\"2e432a4f3c1692777181e8e244ca0e\">antagonist</span> oral anticoagulants (NOACs) or direct oral anticoagulants (DOACs). Dabigatran directly inhibits the activity of thrombin, which is a key <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> involved in the <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> cascade. By inhibiting thrombin, dabigatran prevents the formation of <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> and the subsequent development of blood clots.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options: </strong></p>\n\n<p><strong>Option B - Rivaroxaban: </strong>Rivaroxaban is an oral <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> that belongs to the class of medications known as factor Xa inhibitors. It works by directly inhibiting factor Xa, another <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> involved in the <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> cascade.</p>\n\n<p><strong>Option C -</strong> <strong>Warfarin: </strong>Warfarin is an oral <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> that works by inhibiting the <span class=\"customMeta\" data-dictid=\"3fda45538a1692777199ec2a5478a5\">synthesis</span> of certain <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors in the liver. It is not a direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitor.</p>\n\n<p><strong>Option D -</strong> <strong>Lepirudin: </strong>Lepirudin is an <span class=\"customMeta\" data-dictid=\"27b78a96071692777190f4dfb93430\">intravenous</span> direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> that is used as an <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> in patients with heparin-induced thrombocytopenia. It is not administered orally.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What is the suggested follow-up treatment for a patient post valve replacement?",
      "choices": [
        {
          "id": 0,
          "text": "Warfarin"
        },
        {
          "id": 1,
          "text": "ACE inhibitors"
        },
        {
          "id": 2,
          "text": "Beta blockers"
        },
        {
          "id": 3,
          "text": "Thiazides"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">Warfarin</span> </strong></p>\n\n<ul>\n\t<li>\n\t<p>Among the options provided, a patient who has undergone <span class=\"customMeta\" data-dictid=\"416dd1004a169277720177d9a6adc5\">valve</span> replacement surgery will typically require follow-up treatment with warfarin. <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">Warfarin</span> is an oral <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> medication that works by inhibiting the <span class=\"customMeta\" data-dictid=\"3fda45538a1692777199ec2a5478a5\">synthesis</span> of vitamin K-dependent <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors in the liver. It helps to prevent the formation of blood clots and reduce the risk of thromboembolic events, such as strokes and deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis.</p>\n\t</li>\n\t<li>\n\t<p>After <span class=\"customMeta\" data-dictid=\"416dd1004a169277720177d9a6adc5\">valve</span> replacement surgery, especially with <span class=\"customMeta\" data-dictid=\"9f49b9e654169277719222150eda60\">mechanical heart</span> valves, the risk of <span class=\"customMeta\" data-dictid=\"40d68b98721692777183c42090e023\">blood clot</span> formation on the <span class=\"customMeta\" data-dictid=\"416dd1004a169277720177d9a6adc5\">valve</span> surface is increased. Therefore, long-term <span class=\"customMeta\" data-dictid=\"9beeeb58f6169277718129acb7bd01\">anticoagulation</span> therapy with <span class=\"customMeta\" data-dictid=\"38d84b192c16927772023d96107e4c\">warfarin</span> is often recommended to maintain adequate blood-thinning and prevent clot-related complications.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options: </strong></p>\n\n<p><strong>Option B - <span class=\"customMeta\" data-dictid=\"677d11eaae169277718087b28f2992\">ACE</span> inhibitors: </strong>ACE inhibitors are a class of medications used primarily to manage <span class=\"customMeta\" data-dictid=\"45372f6c361692777189ff3209e642\">hypertension</span> and heart failure. While they have important roles in the treatment of certain <span class=\"customMeta\" data-dictid=\"e1fb96fd2416927771830dfed40e14\">cardiac</span> conditions, they are not typically the primary follow-up treatment after <span class=\"customMeta\" data-dictid=\"416dd1004a169277720177d9a6adc5\">valve</span> replacement surgery.</p>\n\n<p><strong>Option C - <span class=\"customMeta\" data-dictid=\"806eb8418c16927771822855b56695\">Beta</span> blockers: </strong>Beta blockers are commonly used in the management of various <span class=\"customMeta\" data-dictid=\"e2b5f013011692777183ea1b11ed9c\">cardiovascular</span> conditions, such as hypertension, angina, and certain arrhythmias. While <span class=\"customMeta\" data-dictid=\"806eb8418c16927771822855b56695\">beta</span> blockers may be prescribed as part of the post-operative care following <span class=\"customMeta\" data-dictid=\"416dd1004a169277720177d9a6adc5\">valve</span> replacement surgery, they are not specifically indicated as the primary follow-up treatment.</p>\n\n<p><strong>Option D - Thiazides: </strong>Thiazides are a type of <span class=\"customMeta\" data-dictid=\"82987dba8b16927771861f93f6d325\">diuretic</span> medication used to treat <span class=\"customMeta\" data-dictid=\"45372f6c361692777189ff3209e642\">hypertension</span> and edema. They are not typically the primary follow-up treatment after <span class=\"customMeta\" data-dictid=\"416dd1004a169277720177d9a6adc5\">valve</span> replacement surgery.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following is an oral factor Xa inhibitor?",
      "choices": [
        {
          "id": 0,
          "text": "Bivalirudin"
        },
        {
          "id": 1,
          "text": "Dabigatran"
        },
        {
          "id": 2,
          "text": "Rivaroxaban"
        },
        {
          "id": 3,
          "text": "Enoxaparin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Option C - Rivaroxaban:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Rivaroxaban is an<strong> oral factor Xa inhibitor.</strong> It works by <strong>inhibiting factor Xa</strong>, which is an <strong>important component in the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> cascade</strong>. <strong>Rivaroxaban </strong>is used for various indications, including <strong>prevention and treatment of deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis, <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> embolism, and prevention of stroke and <span class=\"customMeta\" data-dictid=\"8f2e7fd96116927771995b451b5c90\">systemic</span> <span class=\"customMeta\" data-dictid=\"1c07a1135f1692777187f547678386\">embolism</span> in patients with atrial fibrillation.</strong></p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Bivalirudin</strong>: It is a direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> and is administered intravenously. <span class=\"customMeta\" data-dictid=\"61c34205b11692777183fd8eeb79d0\">Bivalirudin</span> is primarily used as an <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> during certain <span class=\"customMeta\" data-dictid=\"e1fb96fd2416927771830dfed40e14\">cardiac</span> procedures.</p>\n\n<p><strong>Option B - Dabigatran:</strong> It is a direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> like bivalirudin, but it is available in an oral formulation. Dabigatran is commonly used for stroke prevention in <span class=\"customMeta\" data-dictid=\"e6a04221a41692777182825f0f08da\">atrial fibrillation</span> and the treatment of <span class=\"customMeta\" data-dictid=\"712bb2d2b716927771867d5505033c\">deep <span class=\"customMeta\" data-dictid=\"75ddd4cc7016927772012e0acd424d\">vein</span> thrombosis</span> and <span class=\"customMeta\" data-dictid=\"10e2dee19e1692777196673db90c23\">pulmonary</span> embolism.</p>\n\n<p><strong>Option D - Enoxaparin</strong>: It is a low <span class=\"customMeta\" data-dictid=\"b2df2436bf1692777193d90e9c0132\">molecular weight</span> <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> (LMWH) that is administered subcutaneously. Enoxaparin acts by enhancing the activity of <span class=\"customMeta\" data-dictid=\"fa202015a216927771814a0dc268ba\">antithrombin</span> III, thereby inhibiting multiple <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors and preventing blood clots.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which one of the following drugs inhibits neutrophil recruitment?",
      "choices": [
        {
          "id": 0,
          "text": "Montelukast"
        },
        {
          "id": 1,
          "text": "Sodium cromolyn"
        },
        {
          "id": 2,
          "text": "Colchicine"
        },
        {
          "id": 3,
          "text": "Febuxostat"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Option C - Colchicine:</strong></p>\n\n<ul>\n\t<li>\n\t<p>It is an anti-inflammatory medication that works by disrupting microtubules in neutrophils, which reduces their ability to migrate to sites of <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and thus inhibits <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> recruitment. It's commonly used to manage <span class=\"customMeta\" data-dictid=\"0b216ac0561692777188160d9a8814\">gout</span> and can be helpful in some <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> conditions.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Montelukast</strong>: Montelukast is a <span class=\"customMeta\" data-dictid=\"5a4fd169911692777191c1cb27b0d7\">leukotriene</span> <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> <span class=\"customMeta\" data-dictid=\"2e432a4f3c1692777181e8e244ca0e\">antagonist</span> used primarily in the management of <span class=\"customMeta\" data-dictid=\"76891bb6e91692777182cda16e1db6\">asthma</span> and allergic rhinitis. While it has anti-inflammatory properties, it doesn't directly <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> recruitment.</p>\n\n<p><strong>Option B - Sodium cromolyn</strong>: Sodium <span class=\"customMeta\" data-dictid=\"d3f7cd4f92169277718588c69a0f10\">cromolyn</span> is a <span class=\"customMeta\" data-dictid=\"1f95a52091169277719133cc234fe0\">mast</span> cell <span class=\"customMeta\" data-dictid=\"ff0ea818d31692777199c92259119a\">stabilizer</span> that is used for the prevention and management of asthma, allergic rhinitis, and other allergic conditions. It helps prevent the release of <span class=\"customMeta\" data-dictid=\"9d21dd5d3116927771907405b181bc\">inflammatory</span> mediators, but it does not specifically <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> recruitment.</p>\n\n<p><strong>Option D - Febuxostat</strong>: Febuxostat is a <span class=\"customMeta\" data-dictid=\"c9a23eabc41692777202d1d98467d5\">xanthine</span> <span class=\"customMeta\" data-dictid=\"4a14dfa14e1692777194882f818d87\">oxidase</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> used to treat <span class=\"customMeta\" data-dictid=\"e22be927921692777189c58bef4715\">hyperuricemia</span> and prevent gout. It doesn't have a direct effect on <span class=\"customMeta\" data-dictid=\"000d23188716927771936c5f2fe74e\">neutrophil</span> recruitment.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which drugs require monitoring of the coagulation profile during therapy?",
      "choices": [
        {
          "id": 0,
          "text": "Fondaparinux"
        },
        {
          "id": 1,
          "text": "Enoxaparin"
        },
        {
          "id": 2,
          "text": "Dabigatran"
        },
        {
          "id": 3,
          "text": "Lepirudin"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Option D - Lepirudin:</strong></p>\n\n<p><strong>Coagulation profile monitoring is needed in therapy with lepirudin. </strong></p>\n\n<ul>\n\t<li>\n\t<p>Lepirudin is a direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> that is mainly used as an <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> during heparin-induced thrombocytopenia.</p>\n\t</li>\n\t<li>\n\t<p>Coagulation profile monitoring, including<strong> <span class=\"customMeta\" data-dictid=\"0f61fd74c41692777180190320f12e\">activated partial <span class=\"customMeta\" data-dictid=\"9b51982d06169277720063c9420fbb\">thromboplastin</span> time</span> </strong>(aPTT), is necessary during <span class=\"customMeta\" data-dictid=\"27c736de691692777191197a0890ed\">lepirudin</span> therapy to ensure appropriate anticoagulation.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Fondaparinux:</strong> Fondaparinux is a <span class=\"customMeta\" data-dictid=\"61fbe2173416927771998e7aa0b432\">synthetic</span> <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> that specifically inhibits factor Xa. It does not require routine <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> profile monitoring.</p>\n\n<p><strong>Option B - Enoxaparin:</strong> Enoxaparin is a low <span class=\"customMeta\" data-dictid=\"b2df2436bf1692777193d90e9c0132\">molecular weight</span> <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> that also inhibits factor Xa. While regular <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> profile monitoring is not necessary, <span class=\"customMeta\" data-dictid=\"53ddc0755c1692777195e8d5f9fc68\">periodic</span> monitoring of <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> count is recommended.</p>\n\n<p><strong>Option C - Dabigatran:</strong> Dabigatran is an oral direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitor. It does not require routine <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> profile monitoring, as it has a predictable <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> effect.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following statements accurately describes prasugrel?",
      "choices": [
        {
          "id": 0,
          "text": "It acts as an P2Y12 agonist"
        },
        {
          "id": 1,
          "text": "It is 10 times less potent than clopidogrel"
        },
        {
          "id": 2,
          "text": "It is a pro drug"
        },
        {
          "id": 3,
          "text": "Omeprazole interferes in its activation to an active metabolite"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Option C - It is a pro drug:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Prasugrel is a thienopyridine <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> agent that is administered in its inactive <span class=\"customMeta\" data-dictid=\"1c0d8a64fa1692777196f90166732c\">prodrug</span> form.</p>\n\t</li>\n\t<li>\n\t<p>It requires <span class=\"customMeta\" data-dictid=\"11d4157da4169277718762144a4fe7\">enzymatic</span> conversion in the liver to its active metabolite, which then <strong>irreversibly inhibits the P2Y12 <span class=\"customMeta\" data-dictid=\"d3f6a49b7416927771802124ccddf0\">adenosine</span> <span class=\"customMeta\" data-dictid=\"e85b7f998a1692777186537b5aeefa\">diphosphate</span> (ADP) <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> on platelets, preventing <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> and aggregation.</strong></p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options: </strong></p>\n\n<p><strong>Option A </strong>-<strong> It acts as a P2Y12 agonist:</strong> Prasugrel acts as a P2Y12 antagonist, not an agonist. It blocks the P2Y12 <span class=\"customMeta\" data-dictid=\"9e4959f6f316927771978bb152d440\">receptor</span> on platelets, leading to <span class=\"customMeta\" data-dictid=\"f03ca2d2a716927771901227bc175a\">inhibition</span> of <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> activation.</p>\n\n<p><strong>Option B - It is 10 times less potent than clopidogrel:</strong> Prasugrel is considered to be more potent than clopidogrel. It has a faster onset of action, greater <span class=\"customMeta\" data-dictid=\"f03ca2d2a716927771901227bc175a\">inhibition</span> of <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> aggregation, and <span class=\"customMeta\" data-dictid=\"10c83adb331692777197f775bec1aa\">reduced</span> inter-individual <span class=\"customMeta\" data-dictid=\"128186f064169277720116e786798a\">variability</span> compared to clopidogrel.</p>\n\n<p><strong>Option D </strong>- <strong>Omeprazole interferes in its <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> to an active metabolite:</strong> Omeprazole, a <span class=\"customMeta\" data-dictid=\"9c823198d61692777196bc71097d6d\">proton</span> pump inhibitor, is known to <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> the <span class=\"customMeta\" data-dictid=\"ba6b77f29316927771807350f86ce2\">activation</span> of clopidogrel to its active metabolite. However, there is no significant interaction between <span class=\"customMeta\" data-dictid=\"67e3dc70bc1692777196f908bfee6b\">prasugrel</span> and <span class=\"customMeta\" data-dictid=\"665f486b4d16927771943fd2cb22f9\">omeprazole</span> that interferes with its activation.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "To which class of drugs does Apixaban belong in?",
      "choices": [
        {
          "id": 0,
          "text": "Antifibrinolytic"
        },
        {
          "id": 1,
          "text": "Factor Xa inhibitors"
        },
        {
          "id": 2,
          "text": "Oral direct thrombin inhibitor"
        },
        {
          "id": 3,
          "text": "Parenteral direct thrombin inhibitor"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct Option B - Factor Xa inhibitors:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Apixaban belongs to the class of drugs known as Factor Xa inhibitors.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Antifibrinolytic:</strong> <span class=\"customMeta\" data-dictid=\"03b359edf81692777181e4a297fbf8\">Antifibrinolytic</span> drugs work by promoting <span class=\"customMeta\" data-dictid=\"5e0b40993316927771844dbf382689\">clot</span> stability and preventing the <span class=\"customMeta\" data-dictid=\"903370f259169277718385f6060dd7\">breakdown</span> of blood clots. Examples of <span class=\"customMeta\" data-dictid=\"03b359edf81692777181e4a297fbf8\">antifibrinolytic</span> drugs include <span class=\"customMeta\" data-dictid=\"02cc005ea6169277720014a43f3a4e\">tranexamic acid</span> and aminocaproic acid. They have a different mechanism of action compared to apixaban.</p>\n\n<p><strong>Option C - Oral direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitor:</strong> Oral direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitors, such as dabigatran, directly <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> the activity of thrombin, which is a key <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> involved in the <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> cascade. These drugs act <span class=\"customMeta\" data-dictid=\"c60a4a11081692777201800de5eef7\">upstream</span> in the <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> process compared to Factor Xa inhibitors like apixaban.</p>\n\n<p><strong>Option D - <span class=\"customMeta\" data-dictid=\"f4eacdbe7b1692777194d7caa2017d\">Parenteral</span> direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitor:</strong> <span class=\"customMeta\" data-dictid=\"f4eacdbe7b1692777194d7caa2017d\">Parenteral</span> direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitors are administered through <span class=\"customMeta\" data-dictid=\"3509997646169277719014053aa74d\">injection</span> or <span class=\"customMeta\" data-dictid=\"3562d699c516927771909a426ea8ef\">infusion</span> and directly <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> thrombin.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which drug directly inhibits clotting factor Xa among the options provided?",
      "choices": [
        {
          "id": 0,
          "text": "Apixaban"
        },
        {
          "id": 1,
          "text": "Argatroban"
        },
        {
          "id": 2,
          "text": "Fondaparinux"
        },
        {
          "id": 3,
          "text": "Aspirin"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct Option A - Apixaban:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Apixaban is a direct <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> of <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factor Xa. It belongs to a class of medications known as direct oral anticoagulants (DOACs) or non-vitamin K <span class=\"customMeta\" data-dictid=\"2e432a4f3c1692777181e8e244ca0e\">antagonist</span> oral anticoagulants (NOACs). <span class=\"customMeta\" data-dictid=\"bd0e99d93a169277718152523f2534\">Apixaban</span> specifically inhibits factor Xa, which is a crucial <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> involved in the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> cascade. By inhibiting factor Xa, <span class=\"customMeta\" data-dictid=\"bd0e99d93a169277718152523f2534\">apixaban</span> prevents the formation of <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> and subsequent <span class=\"customMeta\" data-dictid=\"40d68b98721692777183c42090e023\">blood clot</span> formation.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options: </strong></p>\n\n<p><strong>Option B - Argatroban</strong>: <span class=\"customMeta\" data-dictid=\"40cb87270f169277718216469be692\">Argatroban</span> is a direct <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> inhibitor, not a direct <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> of <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factor Xa. It acts by directly inhibiting thrombin, another key <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> involved in the <span class=\"customMeta\" data-dictid=\"42f1e4deb8169277718412c0681a54\">coagulation</span> pathway.</p>\n\n<p><strong>Option C - Fondaparinux</strong>: Fondaparinux is an <span class=\"customMeta\" data-dictid=\"2f73e160ba1692777190d65065c95b\">indirect</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> of <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factor Xa. It selectively binds to <span class=\"customMeta\" data-dictid=\"fa202015a216927771814a0dc268ba\">antithrombin</span> III, which in turn inhibits factor Xa. Although it indirectly inhibits factor Xa, it does not directly <span class=\"customMeta\" data-dictid=\"6b3de87b7c16927771901326efbcd2\">inhibit</span> the <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> itself.</p>\n\n<p><strong>Option D - Aspirin</strong>: <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">Aspirin</span> is not a direct <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> of <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factor Xa. It belongs to the class of medications known as <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> drugs. <span class=\"customMeta\" data-dictid=\"deba671f4716927771828c95a320e5\">Aspirin</span> exerts its <span class=\"customMeta\" data-dictid=\"257da9409416927771815e64ee5df1\">antiplatelet</span> effects by irreversibly inhibiting <span class=\"customMeta\" data-dictid=\"ebd6f6186316927771854d3b6d65be\">cyclooxygenase</span> enzymes, leading to decreased <span class=\"customMeta\" data-dictid=\"3fda45538a1692777199ec2a5478a5\">synthesis</span> of <span class=\"customMeta\" data-dictid=\"96309dcb1c169277720072ad555473\">thromboxane</span> A2, a potent <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> aggregator.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following is used in acute mountain sickness?",
      "choices": [
        {
          "id": 0,
          "text": "Dexamethasone"
        },
        {
          "id": 1,
          "text": "Digoxin"
        },
        {
          "id": 2,
          "text": "Diltiazem"
        },
        {
          "id": 3,
          "text": "Acetazolamide"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Correct Option D - Acetazolamide:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Acetazolamide is a medication used for the prevention and treatment of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"0fe458146b16927771923e5742e418\">mountain sickness</span> (AMS). It is a carbonic <span class=\"customMeta\" data-dictid=\"0a72e82d651692777181ef79d77e61\">anhydrase</span> <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> that works by promoting <span class=\"customMeta\" data-dictid=\"b9356afdba16927771979d068c6587\">renal</span> <span class=\"customMeta\" data-dictid=\"0f7653c9ef1692777187deaa35f749\">excretion</span> of bicarbonate, leading to a mild <span class=\"customMeta\" data-dictid=\"d92cbff33316927771927b4de10a5b\">metabolic</span> acidosis.</p>\n\t</li>\n\t<li>\n\t<p>This <span class=\"customMeta\" data-dictid=\"6caf3a39f416927771807e122b9032\">acidosis</span> stimulates the <span class=\"customMeta\" data-dictid=\"cfad80a0f716927771979aae100f95\">respiratory</span> center in the brain, increasing <span class=\"customMeta\" data-dictid=\"a58f1f33f81692777201ad5e0d60ca\">ventilation</span> and improving oxygenation. By aiding in the adjustment to higher altitudes, <span class=\"customMeta\" data-dictid=\"bd1418cfce1692777180087a9f293c\">acetazolamide</span> can help reduce the symptoms of AMS, such as headache, nausea, and dizziness.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options:</strong></p>\n\n<p><strong>Option A - Dexamethasone:</strong> Dexamethasone is a <span class=\"customMeta\" data-dictid=\"a3e96d80e9169277718551158bbcd4\">corticosteroid</span> medication with anti-inflammatory and <span class=\"customMeta\" data-dictid=\"c3c986cd721692777189b473814b2e\">immunosuppressive</span> properties. While it is not the first-line treatment for <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> <span class=\"customMeta\" data-dictid=\"0fe458146b16927771923e5742e418\">mountain sickness</span> (AMS), it may be used in severe cases or as part of a comprehensive treatment plan for high-altitude <span class=\"customMeta\" data-dictid=\"0ab8536ded1692777184e946b21fa2\">cerebral edema</span> (HACE). HACE is a potentially life-threatening condition characterized by brain <span class=\"customMeta\" data-dictid=\"e3d212ebd316927771996e0c472d4a\">swelling</span> at high altitudes. <span class=\"customMeta\" data-dictid=\"1b969bdd951692777186a2a131511d\">Dexamethasone</span> helps reduce <span class=\"customMeta\" data-dictid=\"e747a47db616927771908bff4b8931\">inflammation</span> and <span class=\"customMeta\" data-dictid=\"e3d212ebd316927771996e0c472d4a\">swelling</span> in the brain, helping to alleviate symptoms and stabilize the condition.</p>\n\n<p><strong>Option B - Digoxin: </strong>Digoxin is a medication from the <span class=\"customMeta\" data-dictid=\"e1fb96fd2416927771830dfed40e14\">cardiac</span> <span class=\"customMeta\" data-dictid=\"1b1b040b0b16927771889ff0286e81\">glycoside</span> class commonly used to treat <span class=\"customMeta\" data-dictid=\"1a5e87d16716927771888f364bce89\">heart failure</span> and certain <span class=\"customMeta\" data-dictid=\"0c0ace39ac16927771898a14fb0cc3\">heart rhythm</span> disorders, such as atrial fibrillation. It is not indicated for the treatment of <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> mountain sickness. <span class=\"customMeta\" data-dictid=\"508c1bf22216927771860525d4ef6f\">Digoxin</span> works by increasing the force of contractions in the heart and slowing down the heart rate.</p>\n\n<p><strong>Option C - Diltiazem:</strong> Diltiazem is a <span class=\"customMeta\" data-dictid=\"54de8b79a91692777183e608bc0dd4\">calcium</span> channel <span class=\"customMeta\" data-dictid=\"adecdf9cb2169277718363b8a0e491\">blocker</span> primarily used for the treatment of <span class=\"customMeta\" data-dictid=\"45372f6c361692777189ff3209e642\">hypertension</span> (high blood pressure) and certain <span class=\"customMeta\" data-dictid=\"0c0ace39ac16927771898a14fb0cc3\">heart rhythm</span> disorders. It is not specifically indicated for <span class=\"customMeta\" data-dictid=\"4cdc8161f71692777180df58cafa93\">acute</span> mountain sickness. Diltiazem works by relaxing blood vessels and reducing the workload on the heart by <span class=\"customMeta\" data-dictid=\"9dc12b322016927771830dff673eeb\">blocking</span> the entry of <span class=\"customMeta\" data-dictid=\"54de8b79a91692777183e608bc0dd4\">calcium</span> ions into cells.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "For the action of heparin as an anticoagulant, availability of which of the following chemical substances is needed?",
      "choices": [
        {
          "id": 0,
          "text": "Thrombin"
        },
        {
          "id": 1,
          "text": "Plasmin"
        },
        {
          "id": 2,
          "text": "Antithrombin – III"
        },
        {
          "id": 3,
          "text": "Thrombomodulin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct Option C - Antithrombin-III:</strong></p>\n\n<ul>\n\t<li>\n\t<p>Antithrombin-III is a natural <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> protein present in the bloodstream. <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">Heparin</span> acts as a <span class=\"customMeta\" data-dictid=\"a416d7580c1692777184952da793d1\">cofactor</span> to AT-III, enhancing its <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> activity. The availability of AT-III is crucial for <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> to exert its <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> effect by inhibiting <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> and other <span class=\"customMeta\" data-dictid=\"58c17961c71692777184ab55a9c4df\">clotting</span> factors.</p>\n\t</li>\n</ul>\n\n<p><strong>Incorrect Options: </strong></p>\n\n<p><strong>Option A - Thrombin:</strong> Thrombin is a key <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> in the <span class=\"customMeta\" data-dictid=\"e4eb2cea4416927771832709027264\">blood coagulation</span> <span class=\"customMeta\" data-dictid=\"6826aa04ef16927771833336e53730\">cascade</span> that converts <span class=\"customMeta\" data-dictid=\"a137b7092a16927772025412d4ef05\">fibrinogen</span> to fibrin, leading to the formation of blood clots. While <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">heparin</span> indirectly inhibits <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> by enhancing the activity of antithrombin-III, the availability of <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> itself is not mandatory for heparin's action as an anticoagulant.</p>\n\n<p><strong>Option B - Plasmin:</strong> Plasmin is an <span class=\"customMeta\" data-dictid=\"0f160e4e42169277718771b715516a\">enzyme</span> responsible for fibrinolysis, which is the <span class=\"customMeta\" data-dictid=\"903370f259169277718385f6060dd7\">breakdown</span> of blood clots. It is involved in the <span class=\"customMeta\" data-dictid=\"1924dd4c6e169277718654d32a636f\">dissolution</span> of <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> clots by cleaving <span class=\"customMeta\" data-dictid=\"18c2380be716927772020c9b2863de\">fibrin</span> into smaller fragments. <span class=\"customMeta\" data-dictid=\"050e27829716927771885eddb2620c\">Heparin</span> does not directly affect <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">plasmin</span> activity, so the availability of <span class=\"customMeta\" data-dictid=\"7e525df4331692777195cc62f0899a\">plasmin</span> is not mandatory for heparin's <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> action.</p>\n\n<p><strong>Option D </strong>-<strong> Thrombomodulin:</strong> <span class=\"customMeta\" data-dictid=\"fb836bd50a16927772009674e9917b\">Thrombomodulin</span> is a <span class=\"customMeta\" data-dictid=\"6c9fa3a73216927771888299c86e08\">glycoprotein</span> present on the surface of endothelial cells lining blood vessels. It plays a role in regulating <span class=\"customMeta\" data-dictid=\"e4eb2cea4416927771832709027264\">blood coagulation</span> by binding to <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> and converting its activity from a <span class=\"customMeta\" data-dictid=\"ff2094828c1692777196941a65e6eb\">procoagulant</span> to an anticoagulant. While <span class=\"customMeta\" data-dictid=\"fb836bd50a16927772009674e9917b\">thrombomodulin</span> is important for the regulation of <span class=\"customMeta\" data-dictid=\"ac7e1f394f1692777200c5bb11e4d8\">thrombin</span> activity, it is not directly related to heparin's <span class=\"customMeta\" data-dictid=\"b5fc7729f316927771817f809648f5\">anticoagulant</span> action.</p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    }
  ]
}